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SUMMARY
This dissertation investigates optimization approaches applied to radiation ther-
apy in cancer treatment. Since cancerous cells are surrounded by critical organs and
normal tissues, there is conflicting objectives in the treatment design of providing suf-
ficient radiation dose to tumor region, while avoiding normal healthy cells. In general,
the goal of radiation therapy is to conform the spatial distribution of the prescribed
dose to the tumor volume while minimizing the dose to the surrounding normal struc-
tures. A recent advanced technology, using multi-leaf collimator integrated into linear
accelerator, provides much better opportunities to achieve this goal: the radiother-
apy based on non-uniform radiation beams intensities is called Intensity-Modulated
Radiation Therapy.
In this thesis, we offer a quadratic mixed integer programming approach to deter-
mine optimal beam orientations and beamlets intensity simultaneously. The problems
generated from real patient cases are large-scale dense instances due to the physics
of dose contributions from beamlets to volume elements. The research highlights
computational techniques to improve solution times for these intractable instances.
Furthermore, results from this research will provide plans that are clinically accept-
able and superior in plan quality, thus directly improve the curity rate and lower the
normal tissue complication for cancer patients.
xi
CHAPTER I
OVERVIEW: OPTIMIZATION IN INTENSITY
MODULATED RADIATION THERAPY
Eva K. Lee, PhD1,2, Joseph O Deasy, PhD3
1Center for Operations Research in Medicine
School of Industrial and Systems Engineering
Georgia Institute of Technology
Atlanta GA 30332-0205, USA
2Winship Cancer Institute and Department of Radiation Oncology
Emory University School of Medicine
3Division of Bioinformatics and Outcomes Research
Department of Radiation Oncology
Washington University School of Medicine
4921 Parkview Place, LL, Campus Box 8224
St. Louis, MO 63110
Abstract
In this chapter, we provide an overview and some computational challenges in
intensity modulated radiation therapy. This chapter is an article written by Lee and
Deasy for SIAM Views and News. Here, experience with a mixed-integer program-
ming treatment planning model is described. The MIP model allows simultaneous
optimization over the space of beamlet intensity weights and beam and couch angles.
The model uses two classes of decision variables to capture the beam configuration
and intensities simultaneously. Binary (0/1) variables are used to capture “on” or
1
“off” or “yes” or “no” decisions for each field, and nonnegative continuous variables
are used to represent intensities of beamlets. Binary and continuous variables are
also used for each voxel to capture dose level and dose deviation from target bounds.
The treatment planning model was designed to explicitly incorporate the following
planning constraints: (a) upper/lower/mean dose-based constraints, (b) dose-volume
and equivalent-uniform-dose constraints for critical structures, (c) homogeneity con-
straints (underdose/overdose) for the planning target volume (PTV), (d) coverage
constraints for PTV, and (e) maximum number of beams allowed. Results of ap-
plying the MIP Model to a patient case are presented. Brief discussions of recent
linear programming and nonlinear programming treatment planning models are also
described, as is an MIP approach for direct aperture optimization.
Keywords Optimization, Intensity-Modulated Radiation Therapy, Mixed Integer
Programming, Beam Angle and Intensity Map Optimization
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1.1 Introduction
Every year over 1.4 million new cancer cases are diagnosed [95] in the United States,
and over half of the patients receive radiation treatment at some point during the
course of their disease. The key to the effectiveness of radiation therapy for the
treatment of cancer lies both in the fact that the repair mechanisms for cancerous cells
are less efficient than that of normal cells, and the ability to deliver higher doses to the
target volume using “cross-fired” radiation beam. Thus, a dose of radiation sufficient
to kill cancerous cells may not be lethal for nearby healthy tissue. Nevertheless,
avoiding or minimizing radiation exposure to healthy tissue is extremely important.
Using multiple beams of radiation from multiple directions to cross-fire at the
tumor volume provides a method to keep radiation exposure to normal tissue at
relatively low levels, while dose to tumor cells is elevated. The crux of the treatment
planning process involves designing beam profiles (i.e., a collection of beams) that
delivers a sterilizing dose of radiation to the tumor volume, while dose levels to critical
normal tissues are kept below established tolerance levels. Often, one attempts to
design a plan for which the prescription dose isodose surface conforms to the geometric
shape of the specified tumor volume. [48, 109] (The term prescription dose typically
refers to the minimum dose desired to be delivered to the tumor volume; it is generally
physician specified.)
Linear accelerators (LINAC) are common beam delivery units used for external
beam radiotherapy. The table on which the patient lies and the beam delivery mech-
anism for the LINAC rotate about separate orthogonal axes, providing the ability to
adjust the angle and entry point of radiation fields used during treatments. Each field
is further defined by a bank of multi-leaf collimators (MLC), small metallic leaves lo-
cated inside the LINAC treatment unit. These leaves can be opened or closed, and
used to shape the radiation beam as it exits the machine. Figure 1 shows a linear
accelerator.
3
Figure 1: A Linear accelerator used for external beam radiotherapy treatment
Intensity-modulated radiation therapy (IMRT) is an important recent advance in
radiation therapy [110]. In conventional radiotherapy treatment, the planning process
consists of determining a set of external beams that meet, as best as possible, the
clinical dose distribution criteria. In many cases, significant compromises to critical
structure function have to be made to enable a tumoricidal dose to be delivered to
the targets. In IMRT, the radiation fluence is varied across the beam, which allows
a higher degree of conformation to the tumor than previously possible and allows
concave isodose profiles to be generated, which may block, for example, dose to critical
structure anterior or posterior to the target from that view. Specifically, not only is
the shape of the beam controlled, but combinations of open and closed multileaf
collimators modulate the intensity as well. For this reason, IMRT provides improved
delivery control over conventional treatment. Indeed, it provides an unprecedented
capability to dynamically vary the dose to accommodate the shape of the tumor from
different angles, and to spare normal tissues and organs-at-risk (OAR) that may be
potentially harmed during treatment.
Due to the complexity of the beam intensity profile associated with IMRT, there
4
has been a tremendous research effort among medical physicists and radiation oncolo-
gists related to IMRT treatment planning and delivery, and there remain many oppor-
tunities for computational advances, particularly in treatment design. A computer-
driven optimization algorithm must be used to determine the beam fluences (intensity
maps) that provide the best compromise between target underdosing, target overdos-
ing and critical structure overdosing. The textbook by Webb [110] has a good list of
references for IMRT optimization.
Figure 2: The treatment of a head-and-neck case via IMRT. Shown is a 3D view
of the patient, the planning tumor volume (PTV), yellow; the spinal cord, pink; and
the parotid glands, red. The 9 beams, shown with gray levels, reflect the modulated
radiation intensity. (Use with permission from [39])
In Sections 2.1, 2.2, we describe the treatment planning problem for IMRT, and
discuss relevant input data and the dose matrix. In Section 2.3, we discuss our
experience of a mixed integer programming treatment planning model. The mixed
integer programming model allows one to simultaneously incorporate dose coverage,
underdose, overdose, homogeneity and conformity criteria on the tumor volume; dose
volume restrictions on the critical structures (how much volume can receive more than
a specified dose); and physical constraints on the total number of beams. Section
2.4 describes briefly the associated clinical results, and Section 2.5 provides a very
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brief discussion of current mathematical programming approaches. Summary and
discussion is presented in Section 3.
1.2 Intensity-Modulated Radiation Therapy Treatment Plan-
ning
Treatment planning in intensity modulated radiation therapy consists of a sequence
of steps:
• Acquiring a 3D image of the affected region
• Delineating target volumes and healthy anatomical structures
• Selecting the appropriate radiation source and energy
• Selecting a set of beam angles for use in treatment
• Computing dose from each beam
• Performing intensity map optimization for the selected beams
• Developing optimal collimator sequences for actual delivery
These steps can be performed sequentially, or some can be combined together,
resulting in complex numerical problems. In the sections presented herein, much of
the description follows our recent work on mixed integer programming in this area
[55, 56]. Very brief discussions on linear programming and nonlinear programming
approaches are included.
1.2.1 Input Data and Dose Calculation
Image Acquisition and Segmentation. The planning process begins when the pa-
tient is diagnosed with a tumor mass and radiation is selected as part of the treatment
regime. A 3D image, or volumetric study-set, of the affected region, which contains
the tumor mass and the surrounding areas, is acquired via computed tomography
(CT) scans. These CT data are used for treatment planning, and electron density
6
information derived from them are used in the photon dose calculations. Addition-
ally, magnetic resonance imaging (MRI) scans may be acquired, fused with the CT
volumetric study-set, and used to more accurately identify the location and extent
of some tumors – especially those in the brain. Based on these scans, the physician
outlines the tumor, and also outlines anatomic structures that need to be held to a
low dose during treatment.
It is common practice to identify three “volumes” associated with the tumor. The
gross tumor volume (GTV) represents the volume that encompasses the imageable or
palpable macroscopic disease; that is, the disease that can be detected and localized
by the oncologist. The clinical target volume (CTV) expands the GTV to include
regions of suspected microscopic disease. The delineation of the CTV depends heavily
on a priori knowledge of the behavior of a given tumor type. For a given GTV, tumor
histologic features, and patient type, a set of probabilities exist (imperfectly known)
that the tumor will, or will not, extend microscopically into a given regional organ or
lymph node. However, accurate specific data are usually not available to the radiation
oncologist, only general principles are known. A more quantitative and consistent
definition of the CTV is an important need. The planning target volume (PTV)
includes additional margins for anatomical and patient setup uncertainties related
to organ and patient movement over time. All volumetric data is discretized into
voxels (point representations of volume properties) at a granularity that is conducive
both to generating a realistic model and to ensuring that the resulting treatment
planning instances are tractable (i.e., capable of being solved in a reasonable amount
of computational time for practical clinical usage).
Dose Calculation Radiation dose, measured in Gray (Gy), is energy (Joules) de-
posited locally per unit mass (kg). Fluence for external beam photon radiation is
defined mathematically by the number of photon crossings per surface area. Dose
tends to be proportional to fluence, but is also influenced by photons and electrons
7
scattered in the patient’s tissues as well as the incident energy and media involved.
The calculation of the dose distribution associated with IMRT delivery is a crit-
ical aspect of the IMRT optimization and delivery processes. The calculated dose
distribution from each candidate set of plan parameters is evaluated at each iteration
or at the end of the optimization process, and the objective function values (costs or
scores) for the iterative optimization are typically obtained by analysis of the dose
distribution. For most systems, after the fluence-optimized plan is obtained, another
dose calculation/optimization procedure, called leaf sequencing, is performed which
first breaks the beams up into machine-deliverable multileaf sequencing steps, and
then includes a final dose calculation step based on the details of the multileaf field
shapes.
One of the most commonly used IMRT dose calculation algorithms involves a
simple pencil beam method and is usually part of a broader class of correction-based
dose-calculation algorithms [2, 66]. While these models offer significant speed advan-
tages for use in the optimization code, they have varying limitations in accuracy.
In contrast, convolution/superposition, energy deposition kernel-based approaches
can take into account beam energy, geometry, beam modifiers, patient contour, and
electron density distribution [1, 8, 15, 67, 70]. Both the convolution method and the
Monte Carlo method compute the dose per unit energy fluence (or fluence) incident
on the patient.
Although it is clear that improved dose-calculation accuracy afforded by the
convolution-type calculations may be important for IMRT, the long calculation times
make this difficult.
Recently, significant progress has been made in the development of Monte Carlo
calculation algorithms for photon beams, which simulate particle tracks individually,
that are fast enough to compete with other current methods [17, 40, 90, 91]. In
several situations, the Monte Carlo method is likely to be even more accurate than
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the convolution method [111]. For example, multiple scatter (second and higher
order scatter) may be perturbed near the surface of a patient and the Monte Carlo
method may be able to account for this as long as the number of simulated particles
is sufficient. Direct Monte Carlo simulation may be the only option for achieving
accurate dose computations in these complex situations. However, the application of
Monte Carlo methods to optimization for IMRT is an area that requires much more
work before relevant results will be available.
Access and usage of realistic radiotherapy data can be facilitated by using an open-
source toolbox, developed by Deasy et al [29], which enables users to import clinical
plan data into Matlab for viewing and manipulation, and furthermore includes tools
to generate the dose influence matrices.
1.2.2 Treatment Planning Strategies
In a strategy known as forward treatment planning, the beam geometry (beam ori-
entation, shape, modifier, beam weights, etc.) is first defined, followed by calculation
of the 3D dose distribution. After qualitative review of the dose distribution by the
treatment planner and/or radiation oncologist, plan improvement is often attempted
by modifying the initial geometry (e.g., changing the beam weights and/or modifiers,
adding another beam), to improve the target dose coverage and/or decrease the dose
in the organs at risk. This forward planning process is repeated until a satisfactory
plan is generated. As one can imagine, this is a time consuming approach to treatment
planning.
In newer inverse treatment planning, the focus is on the desired outcome (e.g.,
a specified dose distribution or tumor control probability (TCP) and normal tissue
complication probability (NTCP)) rather than on how the outcome is achieved. The
user of the system specifies the goals; the computer (optimization system) then adjusts
the beam parameters (mainly the intensities) iteratively in an attempt to achieve the
9
desired outcome. After review of the computer optimized dose distribution, some
modification of the desired outcome and adjustment of the relative importance of
each end point might be needed if the physician is not satisfied with the dose to the
target volume or organs-at-risk (OARs).
Clearly, optimization is a classical inverse planning approach: constraints and an
objective function are utilized to guide the optimization solver to select a plan with
pre-specified clinical properties. Beginning with the work of Bahr et al [5] in the
late 60’s, a number of research articles, authored primarily by medical researchers,
discussed the use of mathematical programming and other optimization techniques
in conventional external beam radiation treatment planning [27, 50, 51, 52, 54, 87,
96, 100, 117].
Much of IMRT treatment planning research has focused on the determination of
the fluence map[11, 13, 16, 18, 19, 24, 28, 36, 39, 41, 42, 43, 71, 72, 109, 113]; that is,
the radiation intensity or beam weights associated to each of the small beamlets of
a selected radiation field/beam. However, the determination of beam angles, shapes,
modifiers, couch positions and radiation energy to be used are best modelled using
discrete variables.
At present, most IMRT optimization systems use dose-based and/or dose-volume-
based criteria. One method commonly used to create dose-based and dose-volume
objective functions involves minimizing the variance of the dose relative to the pre-
scribed dose for the target volumes or dose limits for the organs at risk. This type
of objective function has been used for traditional radiation therapy treatment op-
timization for the past several decades [97]. Variance is defined as the sum of the
squares of the differences between the calculated dose and the prescribed dose or
dose limit. Thus, a typical dose-based or dose-volume-based objective function is
the sum of the variance terms representing each anatomic structure multiplied with
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appropriate penalty factors (i.e., importance factors). Just as in conventional radi-
ation therapy [23], the resulting unconstrained quadratic programming problem is
often solved via the gradient method [96, 113], although the inclusion of dose-volume
constraints makes the problem non-convex [30].
Within the optimization community, linear programming and nonlinear program-
ming have been used to determine the optimal intensity map [86, 92], while mixed
integer programming has been introduced to simultaneously determine the optimal
beam angles and beam intensities [55, 56], and in finding optimal apertures for radi-
ation delivery [83]. Below, we describe the MIP models formulated for simultaneous
beam angle and intensity map optimization, closely following the presentation in Lee
et al [55, 56]. Results from a patient case will be briefly summarized. We then briefly
describe linear and nonlinear programming approaches by others. Besides mathemat-
ical programming approaches, heuristic approaches — such as simulated annealing
and genetic algorithms — have been commonly used for radiation therapy treatment
optimization.
1.2.3 Mixed Integer Programming Treatment Planning Models
The treatment planning models in [55, 56] use two classes of decision variables to
capture the beam configuration and intensities simultaneously: Binary (0/1) variables
are used to capture “on” or “off” or “yes” or “no” decisions for each field, and
nonnegative continuous variables are used to represent intensities of beamlets. Binary
and continuous variables are also used for each voxel to capture dose level and dose
deviation from target bounds. Below, we provide the mathematical description of the
treatment planning models.
Let B denote the set of candidate beams (each with an associated beam angle), and
letNi denote the set of beamlets (discretized sub-beams – usually rectangular in cross-
section – which comprise the beam) associated with beam i ∈ B. Beamlets associated
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with a beam can only be used when the beam is chosen to be “on.” If a beam is on,
the beamlets with positive dose intensity will contribute a certain amount of radiation
dosage to each voxel in the target volume and other anatomical structures. Once the
set of potential beamlet intensities is specified, the total radiation dose received at
each voxel can be modelled. Let wij ≥ 0 denote the intensity of beamlet j from beam








where DP,ij denotes the dose per monitor unit intensity contribution to voxel P from
beamlet j in beam i. Various dose constraints are involved in the design of treatment
plans. Clinically prescribed lower and upper bounds, say LP and UP , for dose at










DP,ij wij ≤ UP . (2)
Our model also allows selection of optimal beam angles out of a collection of
candidate beams. Thus, the resulting plan returns the optimal beam geometry as
well as beam intensities.
Let xi be a binary variable denoting the use or non-use of beam i. The following
constraints limit the total number of beams used in the final plan and ensure that
beamlet intensities are zero for beams not chosen:
∑
i∈B
xi ≤ Bmax and wij ≤Mixi (3)
Here, Bmax is the maximum number of beams desired in an optimal plan, and Mi is
a positive constant that can be chosen as the largest possible intensity emitted from
beam i.
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For each voxel in each anatomical structure, we associate one binary variable
and one continuous variable to capture whether or not desired dose level is achieved
and the deviation of received dose from desired dose. We also impose additional
constraints into our treatment plan design, as discussed below.
Clinically, it may be desirable to incorporate coverage constraints within the
model. For example, the clinicians may consider that it is acceptable if, say, 95%
of the PTV receives the prescription dose, PrDose. Such a coverage requirement can





DP,ijwij − rP = PrDose, P ∈ PTV (4)
rP ≤ DODPTVvP (5)
rP ≥ DUDPTV(vP − 1) (6)∑
P∈PTV
vP ≥ α|PTV |. (7)
Here, rP is a real-valued variable that measures the discrepancy between prescription
dose and actual dose; vP is a 0/1 variable that captures whether voxel P is above or
below the prescription dose bounds or not; α corresponds to the minimum percentage
of coverage required (e.g., α = 0.95); DODPTV and D
UD
PTV are the maximum overdose and
maximum underdose levels tolerated for tumor cells; and |PTV | represents the total
number of voxels used to represent the planning target volume. The values DODPTV and
DUDPTV can be chosen according to the homogeneity level desired by the clinician for
the resulting plan. If rP 0, then voxel P receives sufficient radiation dose to cover
the prescribed dose. In this case, vP = 1 and the amount of radiation for voxel P
above the prescribed dose is controlled by the maximum-allowed-overdose constant,
DODPTV. Similarly, when rP < 0, voxel P is underdosed, and the amount of underdose
is limited by DUDPTV. In this case, vP = 0.
By design, constraints (5) and (6) serve two purposes: 1) they capture the number
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of PTV voxels satisfying the prescription dose, and 2) they provide a means of con-
trolling underdose, overdose, and dose homogeneity in the tumor. For the latter, the
ratio (PrDose +DODPTV)/(PrDose −DUDPTV) can be viewed as an implied PTV homogene-
ity constraint associated with the model. Using a model with a smaller homogeneity
constraint can be expected to result in a more homogeneous plan. Constraint (7)
corresponds to the coverage level desired by the clinician.
Recently Equation (4) has been used to capture dose gradient fall-off when 100%
tumor coverage is demanded. This was achieved by minimizing the dose surrounding
the tumor region [54]. For IMRT planning optimization, it alone was used to model
the deviation from prescribed dose for the PTV [19, 25, 113]. In these studies, a
nonlinear objective function was formulated to steer the gradient-based optimization
engine towards achieving the prescribed dose for the target volume; specifically, the
objective was to minimize the sum of dose deviation across the target volume: ‖r‖q =
(
∑
P |rP |q)1/q (with no imposed constraints). When q = 2, this is a least-squares
problem.
It is desirable that dose received by radiation sensitive organs/tissues other than
the tumor volume should be controlled to reduce the risk of injury. Thus, for other
anatomical structures involved in the planning process, along with the basic dose
constraints given in (2), additional binary variables are employed for modelling the
dose-volume-tolerance relationships. To incorporate this concept into the model, let
αk, βk ∈ (0, 1] for k in some index set K. (In our implementations, the cardinality of
the index set K is typically between 3 and 10 but could be larger.) The following set
of constraints ensures that at least 100βk% of the voxels in an organ-at-risk, OAR,











DP,ijwij ≤ [αk PrDose]yαkP +Dmaxz
OAR
P , P ∈ OAR (8)∑
P∈OAR
yαkP ≥ βk|OAR | (9)
yαkP + z
OAR





P for αk1 ≤ αk2 (11)
Here, Dmax is the maximum dose allowed for OAR (often determined by the maxi-
mum dose thought to be well-tolerated), and αk, βk combinations are patient and
tumor specific. When the total dose received by a voxel P is less than αk PrDose,
yαkP = 1, and this contributes to a voxel count in Constraint (9). When it does not
satisfy the dose bound, yαkP = 0, and in this case the dose will be forced to be lower
than the maximum dose tolerance allowed, Dmax, and zOARP = 1. Note that by us-
ing discrete variables to represent each voxel and controlling the number of points
satisfying a certain dose level, we can impose strict dose-volume criteria within the
solution space. This is in contrast to the common approach of incorporating “soft”
dose-volume criteria into a composite objective function [113]. Langer[51] was the
first to apply MIP ideas to model dose-volume relationships in conventional radia-
tion therapy. For IMRT, the challenge is that the resulting problem instances are
large-scale (involving hundreds of thousands or even millions of inequalities), and are
computationally taxing and difficult to solve without the development of specialized
algorithms [55].
Besides the commonly used least-squares dose deviation objective function, other
objective functions have been used, including: minimizing the squared radiation
dose to OARs, maximizing the minimum dose to tumor target, maximize/minimize
weighted sum of doses to target and OARs. Other more complex biological objec-
tive functions — involving equivalent uniform dose (the p-norm or generalized mean
value), tumor control probability, and normal tissue complication probability — have
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also been proposed [64, 65, 77, 78, 79, 80, 81, 93, 94].
The MIP treatment planning models for real patient cases involve tens to hundreds
of thousands of binary variables and constraints. Our experience is that the resulting
MIP instances are intractable via commercial MIP solvers. However, we have observed
that, by using specialized algorithms [55], clinically superior treatment plans can be
obtained [56].
1.2.4 Computational Results for a Real Patient Case
We briefly describe a patient study. Input data includes 3D images of tissue to
be treated. On these images, the planning target volume (PTV) is delineated, and
contours of organs-at-risk (OAR) and normal tissue are outlined. In addition to these
structures, a tissue ring of 5 mm thickness is drawn around the PTV. We call this ring
the critical-normal-tissue-ring. In [31] it was demonstrated that this normal tissue
construct can assist in obtaining conformal plans for radiosurgery. In [55, 56], we
have shown its usefulness in designing conformal IMRT plans. For the results herein,
depending on the volume of the anatomical structure, a 3 – 5 mm voxel size (for dose
computation) is used for setting up the MIP model instances.
For each beamlet, the dose per monitor unit intensity to a voxel is calculated.
The total dose per unit intensity deposited to a voxel is equal to the sum of dose per
intensity deposited from each beamlet. For the results described here, 16-24 coplanar
fields of size 10×10 cm2 to 15×15 cm2 are generated as candidate fields, each of which
consists of 400-900 0.5 × 0.5 cm2 beamlets. This results in a large set of candidate
beamlets used for instantiating the treatment planning models.
In [55], we study the effect of maximum beam angles allowed on plan quality. In
[56], five objective functions are considered and contrasted on three different tumor
sites to compare plan quality and to gain understanding of the steering effects of
clinical objectives. Below, we illustrate the results for a head-and-neck case obtained
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via multiple objectives.
Some common metrics for reporting quality of treatment plans include:
• Coverage — Coverage is computed as the ratio of the target volume enclosed by
the prescription isodose surface to the total target volume. Coverage is always
less than or equal to 1.
• Conformity — Conformity is a measure of how well the prescription isodose
surface conforms to the target volume; it is computed as the ratio of the total
volume enclosed by the prescription isodose surface to the target volume en-
closed by this same surface. Conformity is always greater than or equal to 1.
• Homogeneity — The homogeneity index is defined as the ratio of the maximum
dose to the minimum dose received by the tumor volume.
• Mean dose and maximum dose for each critical structure.
• Dose-volume histograms (volume receiving more than each given dose level) and
isodose curves.
Observe that these metrics are not entirely independent. For example, while it is
desirable to obtain a prescription isodose surface big enough to cover the target volume
in order to ensure good coverage, it is also desirable to have this surface “small” in
order to conform to the target volume. In addition, variations in conformity and
coverage affect the amount of irradiation to nearby organs at risk, thus affecting dose
distribution levels of these organs.
Head-and-neck tonsil cancer. We focus on a tonsil cancer case where the PTV is
adjacent to the left submandibular salivary gland. The following structures with their
respective clinical dose limits are considered. PTV should receive 68 Gy; left parotid:
30% ≤ 27 Gy and 100% ≤ 68 Gy; right parotid: 100% ≤ 15 Gy; right submandibular
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Figure 3: Anatomical structures for the head-and-neck. Notation: right parotid
(RP), left parotid (LP), right submandibular gland (RS), left submandibular gland
(LS), spinal cord (SP), brain stem (BS).
gland: 100% ≤ 30 Gy; left submandibular gland: 10% ≤ 27 Gy and 100% ≤ 68 Gy;
larynx: 80% ≤ 30 Gy and 100% ≤ 55 Gy; spinal cord and brainstem: 100% ≤ 45 Gy.
A total of 1501 PTV voxels, 406 critical-normal-tissue-ring voxels, 3247 voxels for
the OARs and 6416 normal tissue voxels were used to instantiate the MIP treatment
model.
Here, we report the results for a plan with a maximum of 7 beams in which the
objectives include minimizing the total dose to the critical structures and optimizing
the PTV conformity. The results are based on the utilization of a specialized branch-
and-bound MIP solver for large-scale external beam radiation [55] that is built on top
of a general-purpose mixed integer research code (MIPSOL) [53]. Figure 4 shows the
dose volume histograms, and Figure 5 shows the isodose curves. Compared to the
clinical plan, we observe the following:
a. For all critical structures, the mean dose and max dose received are drastically
less than the clinical plan.
b. For OARs that are close to the tumor volume, namely the left parotid (<
10mm) and the left submandibular gland (< 10mm), the mean dose received
is significantly reduced (70% and 50%, respectively). The spinal cord enjoys
moderate dose reduction (33%).
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c. The coverage constraint and the objective helped in achieving 98% coverage.
Underdose and overdose constraints kept minimum and maximum dose to the
tumor relatively uniform, with a homogeneity index of 1.24. And the confor-
mity objective helped to achieve a superior conformity value of 1.34. These all
improve over the clinical plan, which had 97% coverage, and scores of 1.4 for
homogeneity, and 1.6 for conformity.
d. The total overall monitor units of radiation from the MIP optimized plan is less
than that from the clinical plan, indicating that the plan uses less radiation but
yet can still deliver the required prescription dose to the tumor, thus sparing
excessive radiation dose to the critical structures and normal tissue.
It is noteworthy that in contrast to the typically equispaced beams chosen when
beam configurations are pre-selected, the optimal 7-beam plans obtained herein (that
are considered clinically acceptable) do not have equispaced beams. Indeed, the
optimal beam angles returned appear to be non-intuitive, and to depend on PTV
size and geometry and the spatial relationship between the tumor and the critical
structures.
Figure 4: Dose-volume histogram for the head-and-neck for the MIP model with
objective of minimizing the OARs dose and optimizing prescription dose conformity
to tumor.
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1.2.5 Other Mathematical Programming Approaches
As previously mentioned, linear and nonlinear programming have long been used
for radiation therapy treatment optimization [5, 86, 87]. Lacking discrete variables,
LP and NLP models typically use a pre-selected beam configuration, and focus on
determining beam intensities. Below, we briefly outline some recent approaches in
this area.
Simplified least-squares objective function and dose-volume constraints:
In [86], using pre-selected beam angles, linear programming approaches were used
to determine the associated optimal intensity map. The authors approximated the
least-squares objective function measuring deviation of tumor voxel dose from pre-
scribed dose via a piecewise linear function. They also utilized conditional value-
at-risk (CVaR) constraints to control the mean dose received by subsets of voxels
receiving the highest or lowest doses among all voxels in a given structure. Two
forms of such constraints were used:
(i) lower α-CVaR: The average dose received by the subset of a target of relative
volume 1-α receiving the lowest doses must be at least equal to Lα.
(ii) upper α-CVaR: The average dose received by the subset of a structure of relative
volume 1-α receiving the highest doses may be no more than Uα.
Figure 5: Isodose curves for the head-and-neck case. The critical-normal-tissue-ring
is represented by the dotted curve.
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CVaR constraints were originally proposed by Rockafellar and Uryasev [85] to for-
mulate risk management constraints in terms of the tail means of distributions of







max{0, DP (w)− ζ̄αS (w)} ≤ UαS , (12)
where UαS is an upper bound target, DP (w) is the total dose from intensity vector w
for voxel P , and ζ̄αS (w) denotes the smallest dose level with the property that no more
than 100(1−α) percent of the structure S receives a larger dose. The authors showed
that including such partial-volume constraints to bound the tail averages of the dif-
ferential dose-volume histograms of structures helps to improve dose homogeneity to
the target and to spare dose to critical structures.
Nonlinear programming approach: Sheperd et al [92] summarized several LP
and NLP models for determining optimal intensity maps. To model dose-volume
constraints, they applied a nonlinear error function approach. Their problem in-
volved minimizing the standard objective of sum of the square differences between
the prescribed and the actual doses over all of the voxels in the tumor, subject to
two partial volume constraints — to OARs and to normal tissue. For an OAR S, the
partial volume constraint defined on S was:
∑
P∈S
erf(DP (w)− ΛP ) ≤ α|S| (13)
where Λ denotes a selected dose limit and α denotes the fraction of the volume allowed
to exceed this limit. The error function erf(x) realizing the partial volume constraints
is a nonlinear function. (See fig. 4.4 in [92])
The authors also compared this with an MIP approach to model partial volume
constraints on OARs, involving a simplified version of constraints (8) - (11) described
above.
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Direct aperture approaches via mixed integer programming: Preciado-Walters
et al [83] formulated the treatment planning problem as a mixed integer program over
a coupled pair of column generation processes: the first designed to produce intensity
maps for the IMRT beamlet grid, followed by the second to specify protected area
choices aiding in reducing the computational burden of enforcing the dose-volume
restrictions on tissues.
Instead of determining the beamlet intensity for each beam, and then applying
leaf-sequencing to determine delivery patterns, the planning involved first selecting a
fixed set of deliverable beams. For each of these beams, the authors pre-determined
heuristically a set of delivery patterns. They then introduced continuous nonnegative
decision variables xjq to represent the assigned intensity to whole pattern q of beam







where xjq ≥ 0, Qj is the set of patterns for beam j, and aPjq is the implied dose
coefficient of pattern q from beam j at voxel P when the pattern q is constructed.
The resulting MIP model for treatment planning employed the objective function
of maximizing the minimum tumor dose. Similar to the above MIP models, the
constraints include upper and lower dose bounds on tumor voxels, and upper dose
bounds for healthy tissues. Dose-volume constraints are formulated just as constraints
(8) - (11) above.
1.3 Summary and Discussion
This article provides a brief overview of optimization issues in intensity-modulated
radiation therapy, and summarizes our experience with an integer programming ap-
proach. The MIP model described allows simultaneous optimization over the space
of beamlet intensity weights and beam angles. Based on experiments with clinical
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data, this approach can return good plans that are clinically acceptable and practi-
cal. This work is distinguished from recent IMRT research in several ways. First,
in previous methods beam angles are selected prior to intensity map optimization.
Herein, we employ 0/1 variables to model the set of candidate beams, and thereby
allow the optimization process itself to select optimal beams. Second, instead of in-
corporating dose-volume criteria within the objective function as in previous work,
herein, a combination of discrete and continuous variables associated with each voxel
provides a mechanism to strictly enforce dose-volume criteria within the constraints.
The challenge of using MIP modelling for IMRT is that the resulting instances are
very large-scale, and since general MIP is NP-hard, specialized algorithms designed
to solve IMRT instances are required. Third, incorporating the critical-normal-tissue-
ring can improve conformity in general tumor sites, without addition of other dose-
shaping structures. In general, our MIP approach uses constraints to control a variety
of clinical criteria (coverage, homogeneity, underdose to PTV, overdose to PTV, dose-
volume limits on organs-at-risk and normal tissue), while assigning an objective to
help with the solution search. The model can also be expanded to incorporate energy
selection, couch angles and other treatment parameters.
Patient studies indicate that using the MIP approach, one can produce good
clinical plans that aggressively lower OAR dose below pre-imposed levels without
compromising local tumor control [56]. This is appealing since lower OAR dose should
translate to lower normal tissue complication probability.
Computationally, the specialized optimization engine returns good feasible solu-
tions within 30 minutes. We have performed standard leaf-sequencing techniques on
the resulting optimal intensity map, and showed that returned plans are deliverable.
The results provide evidence that the MIP approach is viable in producing good
treatment plans that can potentially lead to significant improvement in local tumor
control and reduction in normal tissue complication.
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With pre-selected beam angles, other approaches such as linear programming [86]
and nonlinear programming [92, 113] can be used for intensity map optimization.
Comparisons are needed to gauge the quality of these plans versus those from MIP
approaches. Direct aperture optimization [83] is appealing, since resulting segments
are implementable directly. Again, comparisons are needed to determine the effec-
tiveness, advantages and tradeoffs among different planning optimization methods.
Other computational challenges actively pursued by medical physics experts in-
clude image segmentation, planning under uncertainties, biological modelling, leaf-
sequencing and treatment outcome analysis.
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In this chapter, we will describe the models and computational investigation re-
lated to fluence map optimization. In Section 2, the convex quadratic programming
problem for FMO is introduced. The problem consists of a dose-based objective func-
tion with constraints for the upper and lower dose bound for each voxel, mean dose
value received by a structure, and nonnegativity of beamlet intensities. In section 3,
computational strategies including matrix reduction and post-processing scheme that
can improve solution time are described. In section 4, the interior point method is
described for solving the FMO problems. The computational results and plan quality
for prostate and head-and-neck cases are summarized in section 5.
Our experiments show that the quadratic programming approach work success-
fully even when we model it with relatively simple parameters for the objective
function. As observed from our computational experiments and the performance
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of Cplexr barrier optimizer, a pure quadratic convex programming problem for FMO
is unusually difficult due to its large-scale and the dense dose matrix. We demonstrate
that a clever implementation of an interior point method can solve the quadratic con-
vex programming problems very quickly. The key to this success involves a proper
way of handling the large-scale and dense columns. Combining matrix reduction and




Intensity-Modulated Radiation Therapy(IMRT) is an advanced form of three-dimensional
conformal radiation therapy. The treatment goal is to conform the spatial distribu-
tion of the prescribed dose to the planning target volume (PTV) while at the same
time minimize the dose to the surrounding normal structures [39]. To determine a
treatment plan, several optimization problems including beam angle selection, flu-
ence map problem, and leaf-sequencing must be solved. In this chapter, we focus on
the fluence map optimization (FMO) problem which is to find the optimal beamlet
intensities given a set of pre-determined beam angles.
Depending on which mathematical model is employed for IMRT optimization
problems, several solution methods have been used. These methods include linear
programming [5, 87], mixed-integer programming [9, 10, 55, 56, 83], gradient method
[12, 96, 113, 118], and simulated annealing [68, 75, 108]. Presently, the most common
models in FMO problems are related to dose-based and dose-volume objective func-
tions which are based on minimizing the weighted sum of the squares of the differences
between the received dose and the prescribed dose or dose limit [14, 96, 113]. And
these types of problems are solved by gradient methods, or via simulated annealing.
In gradient method, the optimization process performs iteratively by updating the
search direction and step size of the next iteration point. There are several gradient
algorithms classified by the way the search direction and the step size are determined.
For radiation therapy planning, the Newton’s method [12, 113] and conjugate gradient
method [96] are commonly used. In addition to these algorithm, Zhang et al [118]
implemented the steepest descent algorithm [84], and the scaled conjugate gradient
algorithm [73] and tested their plan quality with lung and prostate cancer cases.
Their experiments showed that Newton’s method was by far the fastest, followed by
the scaled conjugate gradient algorithm, while the steepest descent algorithm was the
slowest.
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Since the gradient methods are fast, they are often the favorite methods in IMRT
optimization. However, when the gradient methods are used for FMO problems,
multi local minima have been a concern [30]. To obtain an acceptable treatment plan,
many studies have been focused on finding good objective function parameters, i.e.,
importance factors and the prescribed dose for input structures, by trial and errors
or solving the problems iteratively by updating these parameters [112, 115, 116].
Even though some clinical studies [60, 114] showed that solutions from the gradients
methods are sufficiently good, they did not prove the robustness of the gradient
methods against multi local minima.
Since simulated annealing methods can find global or near-global minimum among
multiple minima and do not require explicit forms of objective functions, these tech-
niques have applied successfully to 3D-conformal radiation therapy (3D-CRT) and
IMRT treatment planning. The basic aspect of simulated annealing is that it is
analogous to thermo-dynamics, especially concerning the way that liquids freeze and
crystallize, or that metals cool and anneal. Its solution time depends on a random
generator that creates a new configuration (i.e. beam weights and beam orientations)
and the temperature lowering schedule.
In early applications, classical simulated annealing provided by Kirkpatrick et al
[49] was used for optimizing the beam weights and orientations in 3D-CRT treatment
planning. Unfortunately, the method has been showed to be too slow in obtaining a
solution due to the large number of iterations [107]. Thus, some specified knowledge
to the desired solution was utilized to reduce the number of iterations [76, 108].
Mageras and Mohan [68] adopted the fast simulated annealing provided by Szu and
Hartley [99], which uses the cauchy generator which is more efficient than the classical
simulated annealing.
In general, inverse planning techniques such as the gradient methods are used for
solving FMO problems; while fast simulated annealing techniques are employed to
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find optimal combination of the pre-defined beam orientations [34, 98].
In this chapter, we use the interior point method to solve the constrained FMO
problems. Since the work by Karmarkar [47], interior point methods have been suc-
cessfully applied to solve large scale instances of linear programming problems and
convex quadratic programming problems arising from industrial applications.
In Section 2, the convex quadratic programming problem for FMO is introduced.
The problem consists of a dose-based objective function with constraints for upper
and lower dose bound for each voxel, mean dose value received by a structure, and
nonnegativity of beamlet intensities. In section 3, computational strategies including
matrix reduction and post-processing scheme that can improve solution time are
described. In section 4, the interior point method is described for solving the FMO
problems. The computational results and plan quality for prostate and head-and-neck
cases are summarized in section 5.
2.2 Modelling the Fluence Map Optimization
IMRT plan optimization begins with the patient information consisting of PTV,
Organs-At-Risk (OARs), and normal tissues, which are delineated from CT or MRI
images. In addition to these structures, we include the normal tissue ring drawn
around the PTV with some thickness. Lee et al [54, 56] called this the critical-
normal-tissue-ring, and demonstrated that this construction from normal tissues can
assist in obtaining superior conformal plans for radiosurgery and IMRT plans. For
simplicity, the critical-normal-tissue-ring is considered as one of the OARs in this
study.
2.2.1 Input Data and Dose Calculation
To set up the model instance, each anatomical structure is discretized into voxels. We
note that the size of the problem and the quality of the resulting plan will be affected
by the choice of voxel size and the sampling scheme.
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For FMO, the candidate beam angles are also predetermined. Then for each candi-
date beam, the shaped field of Multi-Leaf Collimator (MLC) is generally determined
based on the PTV shape. In IMRT mechanism, the modulated beams are achieved
by the MLC device attached to the head of the linear accelerator. 2D-shaped fields
of MLC are represented by the discretized small grids, called beamlets. For each
beamlet, the dose per monitor unit intensity to a voxel is calculated. We remark
that computationally, dose calculation remains an important area of research. The
total dose per intensity deposited to a voxel is given by the sum of dose per intensity
deposited from each beamlet.
In our analysis, we employ the Computational Environment for Radiotherapy Re-
search (CERR) software [31] to generate the patient information and dose data for
treatment planning. CERRr, implemented by Deasy’s group at Washington Uni-
versity in St. Louis, works on Matlabr environment and provides various functional
components including the routines of importing and visualizing the AAPM/RTOG
treatment planning format, the contouring tools to edit and/or create anatomical
structures, the routines of generating the influence matrix with a beam setup, and
the plan analysis tools to generate and visualize dose-volume histograms, and dose
color-washes from the solution of treatment planning. In particular, the influence ma-
trix of each patient was calculated with the Quadrant Infinite Beam (QIB) algorithm
[46] which is a fast method of 3-D dose calculation based on Ahnesjö’s approximation
[3] of kernel dose deposition patterns.
Let B denotes the set of candidate beams and let Ni denotes the set of beamlets
associated with beam i ∈ B. Given B, let the dose per intensity contribution to a
voxel P from beamlet j in beam i be denoted as DP,(ij). Let wij(>= 0) denotes the










2.2.2.1 Quadratic objective function models
The most common approaches in FMO problems have been related to dose-based





γP (DP w − dP )2 +
∑
P∈OAR
γP H(w, dP )(DP w − dP )2 (16)
where, dP is the specified tolerance dose for a voxel P , γP is the weight parameter for
a voxel P , and H(w, dP ) is a step function defined as
H(w, dP ) =
 1, if DP w > dP0, O.W.
In case that dP = 0 for P ∈ OAR, the step function, H(·, 0), is always 1 and this
results in a simple quadratic equation, γP (DP w)
2. For other cases where dP > 0, we
can also transform the step function into an explicit form. That is, by combining with
some linear constraints, a dose-based objective (39) can be reformed to an explicit





γP (DP w − dP )2 +
∑
P∈OAR
γP (dP vP )
2
S.T. DP w − dP yP = dP , P ∈ OAR
vP − yP ≥ 0, P ∈ OAR
−1 ≤ yP ≤ MP , P ∈ OAR
0 ≤ vP ≤ MP , P ∈ OAR
where, yP is a real-valued variable that measures the discrepancy between specified
tolerance dose and actual dose, vP is a real-valued variable that takes positive actual
dose above the tolerance dose, and MP is a sufficient large number to cover yP and
vP for all P ∈ OAR.
Another popular quadratic objective function is a dose-volume based function. Its
difference from the based-based objective function is on how the step function, H, is
defined. That is, given 0 < dP < dP2 ,
H(w, dP , dP2) =
 1, if dP < DP w < dP20, O.W.
Since a step function, H(w, dP , dP2), penalizes the voxels with the received dose
values between dP and dP2 , the dose-volume based objective function appears to
provide more flexibility. Indeed, proper parameters, dP and dP2 , which are often de-
termined by lengthy trial-and-error approach, yield a better treatment plan. However,
it does not guarantee that the objective functions are convex.
Let fOAR:DV (w) =
∑
P∈OAR γP H(w, dP , dP2)(DP w− dP )2. The following proposi-
tion shows that f is nonconvex.
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Proposition 1 : fOAR:DV (w) is non-convex.
Proof : This can be proved easily by selecting two points w1 and w2 as following:
w1 ∈ {w >= 0 : DP w < dP ∀ P ∈ OAR}
and
w2 ∈ {w >= 0 : DP w > dP2 ∀ P ∈ OAR}.
Note that fOAR:DV (w1) = f
OAR:DV (w2) = 0 and there exists a voxel, P such that
H(λw1 + (1− λ)w2, dP , dP2) = 1 for 0 < λ < 1.
Therefore, we have
fOAR:DV (λw1 + (1− λ)w2) ≥ λfOAR:DV (w1) + (1− λ)fOAR:DV (w2).2
Consequently, when a gradient method is used to solve the problem of minimizing
the dose-volume function, multi local minima traps have been observed. In our study,
we focus on the dose-based objective function which can be transformed into an
explicit quadratic convex program.
2.2.2.2 Constraints for FMO
In our FMO model, we will include some linear constraints used by Lee et al [55] and
Romeijin et al [86]. Those constraints help not only to specify the clinical require-
ments, they will also compensate the weaknesses of the dose-based objective FMO
model.
In many clinical practices, the minimum and maximum dose received by each
voxel P need to be bounded. For a voxel P in PTV, lower and upper bounds, say LP
and UP , are modelled as following:
LP ≤ DP w ≤ UP . (17)
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And for a voxel P ∈ OAR′s and normal tissue, only upper bound constraints are
added:
DP w ≤ UP . (18)
Clinically, upper and/or lower constraints are important as they prevent unex-
pected cold and hot spots in the resulting treatment plan. Moreover, proper dose
limitation on each voxel guides the optimization solver to achieve the desired dose-
volume restrictions. In terms of homogeneity index of PTV, defined as the ratio
of the maximum dose to the minimum dose received by the tumor volume, can be
determined by:




Further, in our model, we have also included the mean dose constraints for a
critical structure, Cs, in PTV or OAR as follow:
∑
P∈Cs
DP w ≤ ζ|Cs| or
∑
P∈Cs
DP w ≥ ζ|Cs| (19)
where ζ is a predetermined mean dose of Cs, and |Cs| denotes the total number of
voxels representing Cs. The mean dose constraints (19) can be extended to various
forms of partial mean dose constraints based on the way the subset Cs is defined. For
example, we can have
∑
P∈Cds
DP w ≤ ζd|Cds |
where Cds = {P ∈ Cs : DP w > d} or Cds = {P ∈ Cs : DP w < d}.
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Table 1: Size and density of dose calculation matrix, D. Here, density of D is
calculated by (# nonzero coeff.) / (size).
Cancer case Size of D # nonzero Density
(# voxels) × (# beamlets) coeff. of D of D (%)
Prostate 70,290 × 1222 8,632,385 10.05
Head-and-neck 114,000 × 1007 8,875,371 7.73
2.3 Matrix Reduction
The size of the dose matrix depends on the size of PTV and OAR, as well as the
number of beam, thus beamlets, used. In general, the dose matrix of a real patient
case is obtained by hundreds of thousand of voxels and thousands of beamlets. This
results in a very large-scale optimization problem.
Moreover the primary and scatter dose from a beamlet to a voxel have been
calculated for accurate dose calculation in order to reveal the actual dose distribution.
The range of scatter dose may be estimated for the purpose of dose calculation. Even
if we cut the pencil beams at a certain radial dose distance, say 1.5 cm [20], the
dose matrix remains relatively dense. This is different from most of the large-scale
instances arising from industries and logistics where they are mostly very sparse (<
0.5 %.). Table 1 shows an example of the size and density of the dose matrices for
two patient cases.
Since the scattered radiation dose can be described as an exponential function of
radial distance between the central ray of the pencil beam and the voxel [3], it falls off
radically as it moves away from the central ray. And for each beamlet, the magnitude
of the scatter dose indicates the contribution relative to the primary. Therefore,
a dose matrix typically consists of large numbers of very small coefficients while its
maximum coefficient is often close to 1. Further, because of the noise occurred during
computation, the maximum value may be comparatively greater than 1. Figure 6
shows the distribution of nonzero coefficients of a dose matrix obtained from a prostate
cancer case. In this example, 48.67 % of the nonzero coefficients are less than 0.005
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while 0.17 % are greater than 1.
We apply the matrix reduction scheme introduced by Lee et al [59] for brachyther-
apy into our IMRT FMO optimization. Specifically, we partition the dose matrix into
submatrices based on the magnitude of the coefficients: for a chosen δ > 0, the matrix
D is split as D = D + D where the elements of D and D make up of as following
dij =
 dij, if dij ≥ δ0, otherwise and dij =
 dij, if dij < δ0, otherwise.
Figure 6: Histograms generated using the nonzero coefficients of a dose matrix for
a prostate cancer case. In X-axis of both graphs, the size of disjoint category is
0.01. The right histogram with Y-axis scaled by log term is designed to display those
extremely low levels of fractional frequencies.
Let P s be the convex region satisfying the constraints (17 − 19) defined at the
section 2. Then the problems can be rewritten as
Min{w∈P s} γH(w, d)(Dw − d)2 (20)
m
Min{w∈P s} γH(w, d){(Dw − d)2 + (Dw)T (2(Dw − d) + Dw)} (21)
By ignoring submatix, D, consisting of small coefficients, our reduction scheme is
to solve the following reduced problem:
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Min{w∈fP s} γH(w, d)(Dw − d)2 (22)
Note that since the feasible region of constraints is also associated with the dose
matrix, it should be changed into P̃ s in the reduced problem. In the case when δ is
sufficiently small, say δ = 0.001, we have observed that the second term of the system
(21), (Dw)T (2(Dw− d) +Dw), does not affect the solution, thus an optimal solution
to the reduced problem is almost identical to the solution of the original problem (20).
Obviously, as δ increases, the solution to the reduced problem offers worse estimate
to the original problem while it the submatrix D becomes sparser, which in terms,
results in faster solution time. This tradeoff phenomenon will be illustrated in detail
at section 2.5.
Let w∗ and w̃ be optimal solutions corresponding to the original (20) and the
reduced problem (22), respectively. In this work, we have also observed as following:
Observation 1 : If δ is relatively small, then Dw∗ ≈ Dw̃.
Therefore, if δ is relatively small, the DVH curves computed with Dw̃ should be
expected to be almost identical to the DVH curves obtained from Dw∗. Figure 7 (a)
shows the comparison DVHs computed with Dw∗ and Dw̃ when δ = 0.04. Moreover,
since D ≥ 0 and w̃ ≥ 0, we have that
Dw̃ ≤ Dw̃ + Dw̃ = Dw̃.
This implies that in case δ is relatively small, the relationship between Dw∗ and
Dw̃ is
Dw∗ ≤ Dw̃.
Figure 7 (b) illustrates DVH curves comparing between Dw∗ and Dw̃. In the
graph, DVH curves generated with Dw̃ appears to be shifted from curves with Dw∗.
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(a) Dw∗ vs Dw̃ (b) Dw∗ vs Dw̃
Figure 7: Dose volume histograms comparing solutions between w∗ and w̃. DVH
curves are plotted for the dose between 25 and 90 Gy. And w̃ is the solution to the
reduced problem with δ = 0.04.
Observation 2 : If δ is relatively small, then the shapes of DVH curves generated
with Dw̃ match closely to the ones generated with Dw∗.
Our idea compensating the deviation from the matrix reduction is based on those
observations.
Based on these observations, we will compensate the deviation from matrix re-
duction via a post-processing scheme. Specifically, we will do post-processing using
the function of DVH values, V(D,C,w)(α), defined as
V(D,C,w)(α) =
|{P ∈ C : DP w ≥ α}|
|C|
(23)
where C is a subset of PTV and/or OAR. The post-processing is to scale the solution









where V −1(·) (β) is the inverse function of V(·)(α). Suppose that θ
∗ is the solution to the
problem (24). Then the final scaled plan is θ∗w̃.
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2.4 Interior-Point Method for Quadratic FMO Problems
Our final model for FMO problems is a linear system with a quadratic convex objective
function and a large number of linear constraints. Therefore, any gradient method,
a favorite with clinicians, is not a good solution method anymore. In this chapter,
we have applied an interior point method to solve these optimization problems. For
simplicity, suppose that the QP problem is formulated as
Min xT Qx/2 + cT x
S.T. Ax = b
0 ≤ x ≤ u
(25)
where x consists of (w, y, v), as introduced at Section 2. Clearly Q is a diagonal
matrix. Thus we can readily extend the interior-point method for linear programming
problems to these quadratic programming problems.
2.4.1 The Primal-Dual interior-point methods
Applying the logarithmic barrier function to eliminate the nonnegativity constraints,
and after adding slack variables, s, to the upper bounds of x, the problem (25) is
transformed into:
Min xT Qx/2 + cT x− µ
∑n
j=1 ln xj − µ
∑n
j=1 ln sj
S.T. Ax = b
x + s = u.
(26)
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Then the lagrangian function of transformed problem (26) is given by:








The first-order necessary conditions for a stationary point of this lagrangian function
(27) are
Ax = b (28)
x + s = u (29)
−Qx + AT ϕ− λ + z = c (30)
XZe = µe (31)
SΛe = µe. (32)
where X, Z, S, and Λ are diagonal matrices with the elements xj, zj, sj, and λj,
respectively, and z is the vector of the dual slack variables.
In the application of interior point method to linear programming problems and
convex quadratic programming problems, its key is to generate a sequence of feasi-
ble solutions {(x s ϕ z λ)T} to the conditions (28) - (32), converging to a solution
with complementarity xT z + sT λ < a predetermined tolerance. Since Karmarkar’s
projective algorithm [47], many algorithms have been proposed. In the view of the
implementation for general-purpose linear programming problems, it is well-known
that the commonest interior-point codes are based on the predictor-corrector algo-
rithm [61, 62, 69]. (In details, see the book written by Nocedal and Wright [82].)
Therefore, we extend and implement the predictor-corrector algorithm to solve the
quadratic FMO problems.
2.4.2 Solving the Normal Equations
The biggest computational burden in interior-point methods is to solve the following
normal equations:
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π = (AΘAT )−1ξ (33)
where, Θ = (Q + X−1Z + S−1Λ)−1. Clearly Θ is a diagonal matrix because Q is a
diagonal in our problems. We assume that A has full row rank. This assumption
makes AΘAT a positive definite symmetric matrix. Thus the equation (33) can be
solved by using a cholesky factorization:
AΘAT = LLT
where, L is a lower triangular matrix. This approach has been applied successfully
to large-scale problems by a sparse column cholesky factorization combined with a
matrix ordering, e.g. minimum local fill-in ordering [63, 88].
However, in case that A contains any dense columns, the efficiency of cholesky
factorization may be devastated by large numbers of fill-ins in AΘAT and L. More-
over, in the FMO problems, a dose matrix D contains thousands of relatively dense
columns. This results in very significant fill-ins. The Schur Complement mechanism
[4, 21] has generally been employed to handle dense columns in linear programming
problems. In this study, we describe, based on the splitting scheme, how the Schur
Complement can be applied to solve the quadratic programming problems in FMO.
Let A = [As Ad], where As and Ad are matrices consisting of the spare and dense






Clearly, As also has full rank in our application to IMRT optimization in case that
A has full row rank. Thus, by using sparse cholesky decomposition, the sparse part
is computed as AsΘsA
T
s = LL
T . Applying Sherman-Morrison Formula to the inverse
of equation (34), we have
(AΘAT )−1 = (LLT )−1 − (LLT )−1Ad(Θd + ATd (LLT )−1Ad)−1ATd (LLT )−1. (35)
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Finally, the normal equation (33) is represented as
(LLT )π = ξ − Ad(Θd + ATd (LLT )−1Ad)−1ATd (LLT )−1ξ. (36)
Therefore, the equation (33) can be solved by the Schur-complement method










2.5 Computational Results and Clinical Comparisons
In our computational experiments, two patient cases of prostate and head-and-neck
were selected, and the treatment input data were generated from CERRr. In addition
to dose matrices, they include the geometry information of beams and the spatial and
organ relational information. The patient information has been used to determine the
model parameters for FMO problems.
2.5.1 Prostate cancer
The prostate cancer case contains of a primary PTV and a secondary PTV, labelled
as PTV7560 and PTV4500, whose prescription doses are specified at 75.6 Gy and 45
Gy, respectively. As their coverage requirements, at least 95 % of each PTV should
receive its prescription dose. To achieve the coverage, the model parameters of the
objective function were manipulated. Consequently, the specified tolerance doses, dP ,
at PTV are shifted by 3.5 % of the prescription dose and the weight parameters, γP ,
at PTV, are determined as
1/(total number of voxels in a structure).
Rectum and bladder are considered critical structures. It is specified that the
dose to both critical structures cannot exceed 85 Gy and that 70 % of rectum and
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bladder should receive less than 70 Gy and 80 Gy, respectively. Further, no voxel of
the normal tissues can receive more than 95 Gy. For the model parameters of OAR,
we use
dP = 0 and γP = 1/(total number of voxels in a structure).
Nine open 6 MV photon fields, selected by experienced clinicians, were used at
the gantry angles of (0◦, 40◦, 80◦, 120◦, 160◦, 200◦, 240◦, 280◦, and 320◦). Typically,
each beam makes up of 20×20 beamlet grids with only beamlets delivering significant
amount of dose to any PTV voxel included into the dose matrix. As a result, 1222
beamlets are selected for this patient. Recall that dose matrices associated with huge
numbers of voxels are extremely large. Thus we have sampled voxels for each organ
based on its importance. This results in reducing the size of dose matrix up to 25%.
We have generated the instance of a quadratic FMO problem with the dose matrix
data and model parameters and solved the instance by our interior point codes, called
QP SOL, as described in Section 2.4. Table 2 shows the size of the QP instance and its
solution time running on a 850 MHz Pentium III Xeon machine. We also compare the
solution time from our QP SOL code to the barrier optimizer from Cplexr. Note that
our QP SOL code run much faster than Cplexr barrier algorithm on this instance.
Table 2: Size of instance and its solution time in prostate case
Cancer case Size of instance Solution time (CPU Sec.)
(# rows) × (# columns) QP SOL / Cplexr
Prostate 35108 × 22712 397.32 / 11065.02
Using CERRr, we evaluated the solution plan via dose-washes, dose-volume his-
togram, and statistical indices. To validate the accuracy in modelling via sampling,
these evaluations are computed with the original dose using the entire set of voxels
(with no sampling). A dose-wash picture illustrates the overall dose distribution from
the obtained optimal plan. As shown in Figure 8, the high doses indicated by reddish
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color cluster on the primary tumor region of PTV7560, while the rectum and bladder
are covered by low doses painted in shades of blue.
Figure 9 shows the dose-volume histograms for PTVs, critical structures, and all
remaining normal tissues. The resulting plan is clinically acceptable and superior as
it satisfies all the requirements in the planning directives. Specifically, 70% of rectum
and bladder received less than 30 Gy, respectively.
Table 19 summarizes the dose statistics to the PTVs. Recall that the homogeneity
is the ratio of maximum dose to minimum dose in the PTV. Conformity is a measure
Figure 8: Dose-washes on a transverse and a sagittal view from the optimal plan
for prostate patient. The color scale bar indicates the level of dose intensity.
Figure 9: Dose-volume histogram generated from the optimal plan to prostate case
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of how well the prescription isodose surface conforms to the target volume. That is,
it is computed as the ratio of the total volume enclosed by the prescription isodose
surface to the target volume enclosed by this same surface. Note that a superior plan
results in homogeneity and conformity indices close to 1. Coverage is computed as
the ratio of the target volume enclosed by the prescription isodose surface to the total
target volume.
Table 3: DVH statistics of PTV7560 and PTV4500
PTV7560 PTV4500
Max (Gy) 83.95 75.25
Mean (Gy) 78.465 46.862




Table 4: DVH statistics of critical structures and unspecified tissues
Rectum Bladder Tissue
Max (Gy) 79.35 82.05 88.05
Mean (Gy) 21.348 20.159 18.478
Min (Gy) 0.05 0.35 0.05
V20 0.415 0.3395 0.3839
V40 0.1749 0.1917 0.078
V60 0.0649 0.1076 0.0108
Table 20 summarizes the dose statistics of rectum, bladder, and all remaining
normal tissues. Vα is the DVH value of which a structure, C, receives greater than or
equal to a dose level α for a solution plan, w: Vα = V(D,C,w)(α). Recall that V(D,C,w)(α)
is described at (23). As shown in Table 19 and 20, the optimal plan spares most of
critical structures and normal tissues while meeting the clinical requirement for the
PTVs.
For computational studies of the matrix reduction, we select several δ values such
as 0.005, 0.01, 0.02, 0.03, 0.04, 0.05, and 0.06. That is, for each δ, the original dose
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matrix D is reduced to the matrix D by taking the coefficients whose value are greater
or equal to δ. Recall that 99.8 % of the coefficients of original dose matrix are less
than 1, and these δ values are determined under the assumption that the maximum
coefficient is 1. For each δ, we created the reduced quadratic problem using the
same model parameters and solved it by using our QP SOL codes. Table 5 shows
the density rates and the solution times for the original problem and the reduced
problems. A density rate is defined as the density ratio of a reduced problem to the
original problem. Figure 10 illustrates that the speed-up related to reduced rates
appear to be superlinear. Here, a reduced rate is obtained by (1 - density rate) and
the speed-up is calculated by
(solution time of original problem)
(solution time of a reduced problem)
.
Let w̃δ be the solution to equation (22) for each reduced problem using δ. Figure
11 shows the DVH graphs of each structure calculated from Dw̃δ. All the DVH curves
of the reduced problem from δ = 0.005 are nearly identical to ones of the original
problem. As δ value increases, the gaps of the DVH curves between the original and
the corresponding reduced problem becomes bigger. However, the shape of all the
Figure 10: Relationship between solution time speed-up and the reduction of
nonzero coefficients in the prostate case.
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Table 5: Density rates and solution times for reduced problems in prostate case.
The computations are run on a 850 MHz Pentium III Xeon machine. Here δ = 0
corresponds to the original instance matrix









DVH curves, except for δ = 0.06, are marginally different from the original. Moreover
for the DVH curves of PTV, the shapes are almost identical except a shift from the
original. Based on these properties, the scaling factor can be determined by equation
(24) to eliminate the effect of the matrix reduction. To compute equation (24), we
set the parameters as follows:
Figure 11: Comparison DVHs among δ values.
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C ← PTV 7560
β1 ← 0.93
β2 ← 0.97.
Since the equation (24) is extremely simple, we can obtain its solution, θ∗, in
few seconds. Figure 12 shows the DVH graphs of bladder and rectum after post
processing. And DVH graphs at Figure 13 compare the original problem with the
reduced problems from each δ after post processing. That is, those DVH curves
are calculated using Dθ∗δ w̃δ. Except from δ = 0.06, the post-processed solutions are
marginally different from the solution to the original problem. Fortunately, these
differences happen around low level of doses. Combining the computational gain
and the quality of the resulting plan, our matrix reduction scheme can improve the
solution time by over 50%.
Figure 12: Comparison of DVHs of bladder and rectum after post processing
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This patient case consists of a primary PTV and two secondary PTVs, whose pre-
scription doses are specified at 72 Gy, 54 Gy and 49.5 Gy, with requirement that at
least 95 % of each PTV should receive the prescription dose. Those PTVs are la-
belled as PTV7200, PTV5400, and PTV4950, respectively. PTV7200 and PTV5400
are wrapped inside PTV4950 to take into account of microscopic disease as well as
the patient movement and setup uncertainty. The model parameters for PTVs are
set to the same way as ones in the prostate case: the specified tolerance doses, dP , are
shifted by 3.5 % of the prescription dose and the weight parameter, γP , are determined
to be 1/(total number of voxels in a structure).
The planning criteria also specifies that the dose to the spinal cord, brainstem,
right parotid, and left parotid can not exceed 45, 54, 76.32, and 76.32 Gy, respectively,
and that 50 % of left and right parotid should receive less than 30 Gy. Further, no
voxel of the normal tissues can exceed 76.32 Gy. In the QP modelling, DHV restriction
of each parotid, Cs, is replaced with a mean dose constraint:
∑
P∈Cs
DP w ≤ 30|Cs|.
For the model parameters of the OARs, any specified tolerance dose is set to 0.
However, since this head-and-neck case is much convoluted in the view of the spatial
geometry of OAR, the weight parameters are determined by combining the size of
voxels and spatial information. All the voxels in OAR are first classified into several
layer sets based on their distance from PTVs. Let lP denotes an important factor
of the layer assigned a voxel, P . In this work, we have designed 6 layers. Then the
weight parameters of the OAR are computed as
γP = lP /(total number of voxels in a structure).
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Seven open 6 MV photon fields, selected by the clinicians, were used at the gantry
angles (90◦, 120◦, 150◦, 180◦, 210◦, 240◦, and 270◦). 1007 beamlets from these beams
are included in the dose matrix. Similar to prostate case, the voxels are sampled based
on their redundancy and importance. And we generated and solved the quadratic
FMO problem on a 850 MHz Pentium III Xeon machine. As shown at Table 6, the
instance from the head-and-neck case is much larger than the prostate case. This
results in comparatively longer solution time by our QP SOL codes, whereas Cplexr
cannot solve this instance and terminated as a result of out of memory occurring
during the cholesky factorization.
Table 6: Size of instance and its solution time in the head-and-neck cancer case. On
Cplexr, the problem is solved by barrier optimizer.
Cancer case Size of instance Solution time (CPU Sec.)
(# rows) × (# columns) QP SOL / Cplexr
Head-and-neck 126,637 × 98,441 1604.4 / Out of Memory
Figure 14: Dose-washes on a transverse and a sagittal view from the QP SOL
optimal solution to the Head-and-Neck case. Color scale bar indicates the level of
dose intensity.
The solution plan was evaluated by several clinical metrics, as discussed in the
prostate case. These metrics are computed using the original dose data and the entire
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Figure 15: Dose-volume histogram generated from the optimal plan to the head-
and-neck case
set of voxels (without sampling). The dose-washes at Figure 14 shows the overall
dose distribution from the optimal plan. The sagittal view illustrates clearly that the
plan delivers most of high doses to PTVs while sparing spinal cord, brainstem, and
remaining tissues. Figure 15 shows the DVH graphs for PTVs, critical structures,
and all remaining normal tissues. Table 7 and 8 summarize the dose statistics of the
optimal solution to the original problem. These DVH graphs and statistics illustrate
the solution to a quadratic FMO problem spares most of critical structures while
satisfies all the requirements in the planning directives. In particular, mean dose
constraints reflected well the DVH restrictions even though about half of the right
parotid intersects with PTV 5400 and/or PTV4950. Note that for critical structures
and normal tissues, the DVH curves and dose statistics are calculated using only the
voxels that are not intersecting with the PTVs.
Table 7: DVH statistics of PTVs
PTV 7200 PTV 5400 PTV 4950
Max (Gy) 80.25 77.15 80.45
Mean (Gy) 74.577 60.23 64.242
Min (Gy) 68.75 52.25 48.35




Table 8: DVH statistics of critical structures and unspecified tissues
Spinal cord Brainstem R. parotid L. parotid Tissue
Max (Gy) 29.65 45.25 74.95 55.75 74.65
Mean (Gy) 8.729 14.521 29.589 17 6.595
Min (Gy) 0.15 0.35 0.25 0.65 0.05
V20 0.073 0.29 0.575 0.338 0.156
V30 0 0.1 0.44 0.141 0.085
V40 0 0.013 0.327 0.09 0.045
V50 0 0 0.224 0.022 0.014
To study the effort of matrix reduction, we select several δ values such as 0.005,
0.01, 0.02, 0.03, 0.04, and 0.05. These δ values are determined under the assumption
that the maximum coefficient of dose matrix is 1. Then a reduced quadratic problem
for each δ is generated using the exact model parameters and solved by our QP
SOL codes. Table 9 shows the density rates and the solution times for the original
problem and the reduced problems. Figure 16 illustrates the speed-up with respect
to the reduced rate. Since the PTVs are too large compared to the critical structures,
the reduction rates are not as impressive as the prostate case. Consequently, the
speed-up is not as prominent as in the prostate case.
Table 9: Density rates and solution times for reduced problems in head-and-neck
case. The computations are run on a 850 MHz Pentium III Xeon machine. Here
δ = 0 corresponds to the original instance matrix








Upon evaluating the DVH graphs for each δ, we have observed the same behavior
of DVH curves as in the prostate case. That is, as δ increases, the DVH curves are
farther away from the original problem while their shapes remain comparable to the
ones from the original problem. In this case, the threshold of DVH shape is 0.04.
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Figure 16: Relationship between solution speed-up and the reduced rate of nonzero
coefficients in the head-and-neck case.
Based on these observations, the scaling factors are computed for equation (24):
C ← PTV 7200
β1 ← 0.93
β2 ← 0.97
DVH graphs in Figure 17 compare the original problem with the reduced problems
for each δ after scaling. In the head-and-neck case, even though the post-processed
solutions do not work as good as those from the prostate case, roughly speaking, the
solutions, except for δ = 0.05, are comparable to the original problem. Further, our
matrix reduction scheme improves the solution by 37%.
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In this Chapter, explicit quadratic convex programming problems combined with lin-
ear dose constraints with a dose-based objective function are formulated for IMRT
fluence map optimization. Our experiments show the quadratic programming ap-
proaches work successfully even when we model it with relatively simple parameters
for the objective function. Obviously, a better combination of model parameters
can be found by manipulating the parameters iteratively which may lead to better
treatment plans.
As observed from our computational experiments and the performance of Cplexr
barrier optimizer, a pure quadratic convex programming problem for FMO is unusu-
ally difficult due to its large-scale and the dense dose matrix. We demonstrate that
a clever implementation of an interior point method can solve the quadratic convex
programming problems very quickly. The key to this success involves a proper way of
handling the large-scale and dense columns. Combining matrix reduction and post-
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Following our analysis on the fluence map optimization, in this chapter, we will
focus on generation of beam angles and fluence map optimization simultaneously via
a novel column generation scheme.
In Section 2 we describe briefly the input data and dose calculation for IMRT
optimization problems and provide the mixed- integer quadratic model. Specially,
the estimator of a DVH function is introduced to represent dose-volume constraints
using linear inequalities. Solution strategy and computational advances are presented
in Section 3 and 4. Specifically, we discuss some techniques that are useful in solving
these large-scale intractable instances. In Section 5 we describe the computational
experiences and present the clinical results illustrating the solution speed and resulting
plan quality from our MIQP approach.
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The proposed MIQP model allows one to optimize simultaneously the beam ori-
entations over the entire space of the gantry angles and the beamlet intensity map.
For computational efficiency, a restricted branch-and-price method is derived to solve
these large-scale MIQP instances arising from clinical cases of prostate and head-
and-neck cancer. Clinical experiments showed that the solutions from our MIQP are
far superior than those plans obtained in by the current best-practice in the clinical
environment.
Beyond drastically improving the computational time, the restricted branch-and-
price method provides an additional bonus: every node consists of only a relatively
small number of beam variables in the branch-and-bound framework. This implies
that in the middle of the solution process, a feasible solution obtained can be clinically
usable, and it can be readily obtained by a few branching steps of the beam variables
that are in the active set
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3.1 Introduction
Intensity-Modulated Radiation Therapy (IMRT) is an advanced technique of three
Dimensional Conformal Radiation Therapy (3D-CRT). Its modulated beam mecha-
nism may provide superior treatment plans to any conventional 3D-CRT, in terms of
better conformal dose distribution of the prescribed dose to the Planning Target Vol-
ume (PTV) as well as much reduced dose to the surrounding normal structures. This
sophisticated delivery mechanism requires solutions to several difficult optimization
problems to be solved during the course of treatment planning.
Much research has focused on determining an optimal beamlet intensity map
and/or optimal beam configuration (or other beam delivery parameters such as field
segments, coach angles, gantry angles, etc). Since the attempt of Bahr et al [5]
for radiotherapy planning in the late 60’s, various mathematical models and solution
approaches have been introduced to optimization problems arising in this area. These
include linear (or piece-wise linear) programming [86, 87], gradient method [12, 96,
113, 118], simulated annealing [68, 75, 108], and mixed-integer programming (MIP)
[9, 10, 83, 55, 57].
Presently, the most common models in the optimization of beamlet intensity map
are related to dose-based and dose-volume objective functions which are based on min-
imizing the weighted sum of the squares of the differences between the received dose
and the prescribed dose or dose limit [14, 39, 96, 113]. And gradient methods, known
as efficient algorithms for unconstrained convex quadratic programming problems, are
generally used to to solve these instances. While simulated annealing methods can
find the global or near-global minimum among multiple minima and do not require
the specific forms of objective functions, they are too slow to applied to a large-scale
instances. Therefore, similar to 3D-CRT treatment planning, these techniques have
popularly been used for the optimization for beam configuration problems.
MIP approaches, state-of-the-art computational techniques, allow one to consider
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both beam angle and fluence map optimization simultaneously. For example, Lee
et al. [55, 57] introduced this approach to determine the optimal beam angles and
beam intensities. Preciado-Walters et al. [83] found a series of segments of multileaf
collimators for radiation delivery.
In this chapter, we extend Lee’s approach [55, 57] to a Mixed-Integer Quadratic
Programming (MIQP) model where the objective function takes on a dose-based
objective function. The computational approach focuses on the design of an efficient
a branch-and-price approach to solve these MIQP instances. Branch-and-price has
been considered an efficient solution approach to solve large-scale MIP instances.
Since Gilmore and Gomory [37, 38]’s researches on the cutting stock problem, branch-
and-price method has been successfully applied to various classes of MIP instances
including vehicle routing problem [32, 33], aircraft fleeting and routing problem [6],
single machine problem [101], bin packing and cutting stock problems [102, 103],
minimum cut clustering problem [45], and generalized assignment problem [89], etc.
In our context, we develop a branch-and-price algorithm for solving large-scale MIQP
arising from IMRT.
In Section 2 we describe briefly the input data and dose calculation for IMRT
optimization problems and provide the mixed- integer quadratic model. Specially,
the estimator of a DVH function is introduced to represent dose-volume constraints
using linear inequalities. Solution strategy and computational advances are presented
in Section 3 and 4. Specifically, we discuss some techniques that are useful in solving
these large-scale intractable instances. In Section 5 we describe the computational
experiences and present the clinical results illustrating the solution speed and resulting
plan quality from our MIQP approach.
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3.2 Modelling IMRT Problem
IMRT plan optimization begins with the patient information consisting of PTV,
Organs-At-Risk (OARs), and normal tissues, which are delineated from CT or MRI
images. In addition to these structures, we include the normal tissue ring drawn
around the PTV with some thickness. Lee et al [54, 56] called this the critical-
normal-tissue-ring, and demonstrated that this construction from normal tissues can
assist in obtaining superior conformal plans for radiosurgery and IMRT plans. For
simplicity, the critical-normal-tissue-ring is considered as one of the OARs in this
study.
3.2.1 Input Data and Dose Calculation
To set up the model instance, each anatomical structure is discretized into voxels. We
note that the size of the problem and the quality of the resulting plan will be affected
by the choice of voxel size and the sampling scheme.
For simultaneously beam angle and fluence map optimization, a large set of can-
didate beam angles are predetermined (30-40). Then for each candidate beam, the
shaped field of Multi-Leaf Collimator (MLC) is generally determined based on the
PTV shape. In IMRT mechanism, the modulated beams are achieved by the MLC
device attached to the head of the linear accelerator. 2D-shaped fields of MLC are rep-
resented by the discretized small grids (called beamlets). For each beamlet, the dose
per monitor unit intensity to a voxel is calculated. Note that in terms of dose compu-
tation, efficient dose calculation approach is an important research area because dose
computations (i.e., Monte Carlo method) associated with a large number of beamlets
are computationally very expensive. The total dose per intensity deposited to a voxel
is equal to the sum of dose per intensity deposited from each beamlet.
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Figure 18: Dose per intensity contribution to a voxel P from beamlet j in beam i.
3.2.2 Basic Quadratic Programming
Let B denotes the index set of predetermined candidate beams and let Ni denotes
the index set of beamlets associated with beam i ∈ B. Given B, let the dose per
intensity contribution to a voxel P from beamlet j in beam i be denoted as DP,(ij).
Figure 18 illustrates the scheme of this dose calculation. Let wij denotes the intensity
of beamlet j in beam i. Let wij(>= 0) denotes the intensity of beamlet j in beam i.







Clinically, the minimum and maximum dose, say LP and UP , received by a voxel
P can be modelled as:
LP ≤ DP w ≤ UP . (38)
It is ideal that for P ∈ OAR or normal tissue, LP = 0. For example of a head-and-
neck cancer case, every voxel in the spinal cord should receive less than 45 Gy. Here,
Gy stands for Gray which is the energy (Joules) deposited locally per unit mass
(Kg). Besides their clinical requirements, proper upper and lower bounds prevent
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unexpected hot and cold spots, respectively. And in terms of homogeneity index
which is defined as the ratio of the maximum dose to the minimum dose received by
the tumor volume, the bounds, LP and UP , for PTV constrain the upper bound of
homogeneity in a solution plan. That is,








γP (DP w − dP )2 +
∑
P∈OAR
γP H(DP w − dP )(DP w − dP )2 (39)
where, dP is the specified tolerance dose for a voxel P , γP is the weight parameter for
a voxel P , and H(DP − dP ) is a step function defined as
H(DP w − dP ) =
 1, if DP > dP0, Otherwise.
In case that dP = 0 for a P ∈ OAR, its step function HP can be ignored and this
results in a simple quadratic term, γP (DP w)
2. For the other cases where dP > 0,
we can consider the relationship between volume of the structure and dose received,
and transform its step function HP explicitly. Consequently, the objective function






γP (DP w − dP )2 +
∑
P∈OAR
γP (dP vP )
2 (40)
S.T. DP w − dP yP = dP , P ∈ OAR (41)
vP − yP ≥ 0, P ∈ OAR (42)
−1 ≤ yP ≤ MP , P ∈ OAR (43)
0 ≤ vP ≤ MP , P ∈ OAR (44)
where, yP is a real-valued variable that measures the discrepancy between specified
tolerance dose and actual dose, vP is a real-valued variable that takes positive actual
dose above the tolerance dose, and MP is a sufficient large number to cover yP and
vP for P ∈ OAR.
3.2.3 Dose-Volume Restrictions
In radiation therapy, it has believed that radiation goes straight through human
body and it is impossible for it to reach PTV without harming OAR and normal
tissue surrounding PTV. Consequently, a part of OAR and/or normal tissue may be
sacrificed in some levels while covering PTV by desired level of prescription dose.
In clinical practice, thus, it is common for oncologists to specify the percentage of
volume a critical organ is allowed to receive a certain among of radiation dose. This
specification is known as the Dose-Volume (DV) restriction. That is, a DV restriction
is typically stated as at most β×100 % of a critical organ is allowed to receive the
dose greater than or equal to α Gy. For example, in a head-and-neck cancer case, at
most 50 % of the parotid can receive a dose greater than or equal to 30 Gy. For PTV,
DV restrictions are sometimes be employed to the upper dose tale (higher than the
prescription doses). Moreover, several levels of DV constraints can be specified on a
single structure to achieve better quality of treatment plan.
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Figure 19: DVH graph and DV constraint represented by Vα( · , w) at a specified
dose level α.
Clinicians use the Dose-Volume Histogram (DVH) to evaluate the quality of a
treatment plan. Let Vα(Si, w) be the value of DVH in which a critical organ, Si ⊆
OAR, receives greater than or equal to a dose level α from a beamlet intensity map,
w. Then, Vα(Si, w) can be calculated as
Vα(Si, w) =
|{P ∈ Si : DP w ≥ α}|
|Si|
(45)
where, | · | denotes the cardinality. As shown in Figure 19, given DP w, ∀ P ∈ Si,
a typical DVH graph is generated by plotting Vαk(Si, w) sequentially at discretized
dose level αk. And at a specified dose level α, DV constraint can be represented by
limiting Vα(Si, w):
Vα(Si, w) ≤ β. (46)
Some investigators [51, 55, 57] suggested mixed-integer programming (MIP) to
formulate DV constraints explicitly. Note that their explicit formulations consists of
binary (or integer) variables representing |{P ∈ Si : DP w ≥ α}|. Because of well-
known difficulty in solving MIP problems, specialized techniques are required to solve
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these instances to produce plans with superior clinical quality.
On the other hand, medical physicists have considered the DV constraints implic-
itly by using the dose-volume objective functions [113] to penalize only those voxels
that receive the doses between two predetermined values d1 and d2 and solving them
via gradient methods, known to be an efficient algorithm for solving unconstrained
convex quadratic programming problems. However, since there exist multiple local
extrema on these functions [22, 30, 114], the final solution may not be a global ex-
trema.
In this chapter, we introduce an estimator of DVH value derived from partial dose
in a dose interval: instead of counting the number of voxels in the set, {P ∈ Si :
DP w ≥ α}, at a dose level α, a DVH estimator is computed based on the relationship
between two partial mean doses in interval (α − δ1, α + δ2). Note that this is the
extension of single mean tail dose [86], in which DV constraints can be approximated
with linear convex constraints, free from integer variables.
Let Ṽ(α,δ) denotes the DVH estimator in dose interval (α− δ1, α + δ2) at α. Then
for given δ1 and δ2, Ṽ(α,δ)(Si, w) is defined as
Ṽ(α,δ)(Si, w) =
∑
P max{0, (Dpw − (α− δ1)} −
∑
P max{0, (Dpw − (α + δ2)}
(δ1 + δ2)|Si|
. (47)
As shown in Figure 20, DVH curves are generated by plotting Ṽ(α,δ)(Si, w) at each
discretized dose level α. Figure 21 plots the comparison of DVH curves generated by
the conventional DVH values and the estimators of DVH value with δ1 = δ2 = 0.5
respectively. Both curves are almost identical to each other. Clearly, in the case that
δ1 and δ2 are sufficiently small and |Si| is sufficiently large, we have
Ṽ(α,δ)(Si, w) ∼= Vα(Si, w).
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Figure 20: DVH graph generated by estimators in dose interval (α− δ/2, α + δ/2)
at α. Here, δ1 and δ2 are set to δ/2 for this example. Note that the area covered by






Figure 21: Comparison of DVH graph between the conventional calculation and the
estimator in dose interval. Here, δ1 = δ2 = 0.5.
Consequently, the inequality constraint (46) can be approximated by two partial




max{0, (Dpw − (α + δ2)} ≤ ξ (48)∑
P
max{0, (Dpw − (α− δ1)} ≤ ξ + β{(δ1 + δ2)|Si|}. (49)
3.2.4 Beam Angle Selection
It is generally believed that increasing the number of beam angles would improve
the quality of treatment plan. However, this may increase beam delivery time which
results in more cost of the treatment and more chances for potential errors con-
nected with patient setup, organs motions, patient movement and increased discom-
fort. Moreover, some researchers [74, 106] pointed out that longer delivery time may
affect cell survival and tumor control probability. Thus, in the clinical and practical
setting, the number of beams used in a final plan needs to be limited by a rela-
tively small number. For example, at most 7 beams are allowed to be used in most
head-and-neck cases.
Let xi be a binary variable denoting the usage of beam i in a treatment plan. That
is, if beam i is to be used then xi = 1, otherwise xi = 0. Given Bmax, the maximum
number of beams desired in an optimal plan, the constraint of the beam selection is
∑
i∈B
xi ≤ Bmax. (50)
Recall that B is the index set of candidate beams. For the optimization problem
of beam orientation, the candidate beams are generally predetermined by discretizing
the entire space of the beam orientation in increments of a spacing unit, θ (for ex-
ample, 5o or 10o). And when beam i is not used, the beamlets corresponding to this
beam should be zero. The following constraints represent the relationship between a
beam and its associate set of beamlets:
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Figure 22: Constraints of beam-angle spacing: a. variables fixed to 0 by the mini-
mum spacing constraints and b. variables fixed by the opposite spacing constraints.
wij ≤Mixi (51)
where Mi is a positive constant that can be chosen as the largest possible intensity
emitted from beam i.
Based on clinical experiments, some researchers provided beam-angle spacing con-
straints to prevent undesirable plans by considering geometric spacing among selected
beams. For example, D’souza et. al’s [35] has shown that directly opposed beams
yield unexpected hot spots in the Corvus planning system. In our analysis, two types
of beam-angle spacing constraints are used. One is for specifying the minimum spac-
ing between geometrically adjacent beams. (See Figure 22. a) Suppose that ∆ is the
minimum angle of geometric spacing allowed between adjacent beams. The minimum
spacing constraints can be modelled as follow:
m+i∑
l=i
xl(θ) ≤ 1,∀ i ∈ B (52)
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where m is the largest number satisfying mδ ≤ ∆ and l(θ) is defined as: if lθ > 360o
then l(θ) = l− b360/θc, otherwise l(θ) = l. Since the minimum spacing constraints do
not allow the selection of adjacent beams within ∆o, the resulting treatment plan is
free from clustering of beams.
The other is to exclude directly (or nearly) opposed beams. As shown in Figure
22. b, if the difference of spacing angle between two beams is almost 180o, both beams
cannot be included in a treatment plan. Suppose that the opposite spacing angle is
180 ±δ̆. Then the constraints can be modelled as
xi + x ˘(i+k)(θ)
≤ 1, k = −m̆,−m̆− 1, ..., 0, ..., m̆, ∀ i ∈ B̆ (53)
where m̆ is the largest number satisfying m̆θ ≤ δ̆, and B̆ is the subset of B by taking
all the indices in the first half space (0o - 180o). And ĭ(θ) is defined to finding the
index of beam angle directly opposed to beam i. That is,
ĭ(θ) := (i + b180/θc)(θ).
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3.3 Solution Strategy: Branch-and-Price Method
The entire system for IMRT optimization problem P is:
Min γyT Qy + cy
S.T. Dw − y = b (54)
Gy −Hz = h (55)
Ew − Fx ≤ 0 (56)∑
i∈B
xi ≤ Bmax (57)
m+i∑
l=i
xl(θ) ≤ 1,∀ i ∈ B (58)
xi + x ˘(i+k)(θ)




x ∈ {0, 1}
where constraints (55) represent the constraints related to the dose-volume con-
straints, coverage constraints, and upper and lower bound constraints of PTV’s and
the critical structures. And constraint (56) represents equation (51). The above sys-
tem has proved to be computational intractable, we will describe a branch-and-price
method to solve these instances.
3.3.1 Branch-and-Price Method
Let Ξ denote the set of beams satisfying the beam selection constraint (50), the beam-
angle spacing constraints (52) and (53). Note that Ξ is bounded. Let Ξ∗ be the set
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defined as Ξ∗ = {x ∈ Ξ : x binary}. Then Ξ∗ is made up of the finite number of
points. Consequently, the binarity of x variables makes Ξ∗ coincides with the extreme
points of its convex hull, conv(Ξ∗). That is, given Ξ∗ = {χ1, ..., χp}, any points χ ∈ Ξ∗





combined with following convexity constraint:
∑
1≤k≤p
λk = 1, where λk ∈ {0, 1}, k = 1, ..., p.
As representing a bounded polyhedron by the convex combination of its extreme
points, Dantzig-Wolfe decomposition [26] is applied to the column generation ap-
proach to integer programming [7, 104]. Finally, the original problem P can be
rewritten into its column generation form, called the master problem (MP):
Min γyT Qy + cy
S.T. Dw − y = b












Since there may be a huge number of generated columns in the column generation
form, it is impossible to solve the instance ofMP containing all these columns. Thus,
a restricted instance, called a restricted master problem (RMP), consisting of only
a subset (i.e., Ξ∗RMP = {χ1̃, ..., χp̃}) of its entire columns is considered in our column
generation method. The general way to solve the mixed integer MP to optimality
performs in a branch-and-bound framework. This is known as branch-and-price [7] or
IP column generation [103]. In the structure of the branch-and-bound tree, a column
generation method is used to solve the relaxation problem of MP at each node. If
the solution to the relaxedMP is feasible to original problem, P , or the lower bound
of the relaxed MP is greater than the objective function value of the incumbent
integral solution, the current node is pruned. Otherwise, branching will occur.
In the case when the relaxation problem of an RMP is LP, the reduced cost, c̄,
is calculated from the optimal solution to the relaxed problem and new column can
be generated by solving the pricing problem:
Min {c̄χ : χ ∈ Ξ∗( or conv(Ξ∗))}.
3.3.2 Column Generation
Since our relaxation problem is QP, we need how to determine the objective function
of a pricing problem. The relaxation problem of the RMP is
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Min γyT Qy + cy
S.T. Dw − y = b (61)




Fχkλk ≤ 0 (63)∑
1̃≤k≤p̃





Let πb, πh, π0, and π1 denote the dual variables to the constraints, (61), (62), (63),
and (64), respectively. Then the dual problem of the relaxed RMP is given as
Max πb
T b + πh
T h + π1 − γρT Qρ
S.T. − πbT + πhT G − 2γρT Q ≤ c (65)
πb
T D − π0T E ≤ 0 (66)
−πhT H ≤ 0 (67)
π0
T Fχk + π1 ≤ 0, 1̃ ≤ k ≤ p̃ (68)
π0 ≥ 0
πb, πh, π1, and ρ : unrestricted.
Suppose that we have an optimal solution to the relaxed RMP . That is, the solu-
tion satisfies all the constraints of its primal and dual problem. Clearly, it guarantees
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the satisfaction of the constraints (68) for the subset, Ξ∗RMP only. Thus we need to
check if the solution is feasible to the entire set, Ξ∗. Similar to Dantzig-Wolfe decom-
position methods applied to the linear programming, a pricing problem is introduced
to find new entering columns with respect to the constraints (68):
Min −π0T Fχ (69)
S.T. χ ∈ Ξ∗ (or, conv(Ξ∗)).
Let χ̃ be the optimal solution to the above sub-problem (69). If π1 > −π0T Fχ̃,
then χ̃ is added into RMP and we proceed to solve the updated RMP . In typical
column generation, this iterative process is performed until π1 ≤ −π0T Fχ̃. From









S.T. χ ∈ Ξ∗ (or, conv(Ξ∗))
where π0i
j and χi denote the element of vectors, π0i and χ, respectively.
3.4 Computational Issues: Implementation
Since a dose coefficient matrix, D, is dense and large scale, it is proven to be difficult to
solve the relaxation problem of theRMP when the columns generated at a node cover
many beam variables, xi. Table 10 shows the solution times of the pure QP instances
of the relaxation problem obtained by the commercial Cplexr barrier optimizer. The
table clearly illustrates the difficulty of solving the relaxation problem itself as well as
the dramatic increase in solution times with addition of only a few beam variables to
RMP . Thus solving the IMRT instances are proven to be very difficult when there
are a huge set of beam variables, since a typical branch-and-price approach requires
the solutions to a large number of RMP relaxations.
75
Table 10: Solution times of the QP relaxation of RMP by the barrier optimizer on
Cplexr
# beams Instance size Cplexr
# rows # columns # nonzeros CPU Times (Sec)
8 26538 11286 792399 9873
10 26845 11595 989907 12182
12 27219 11971 1198756 18933
3.4.1 Restricted Branch-and-Price Method
We propose and investigate a column generation scheme with limited number of orig-
inal binary variables for the beam angles. We call this scheme the restricted branch-
and-price method. This approach begins with partitioning the binary variables, x,
into two subsets: the Active Set, AS, and the Inactive Set, IS. While all the vari-
ables in IS are fixed to 0, only variables in AS are allowed to set be set to 0 or 1.
And when a variable in AS is fixed to 0 by branching (or cutting plane), a variable
in IS can be moved to AS set. Thus we maintain the size of Active Set to a certain
threshold, κ: |AS| ≤ κ.
Thus, sinceRMP consists of the columns generated from at most κ of the original
binary variables, the computational burden in solving the relaxed RMP can be
monitored to make the solution time practical. Moreover, at each node of the branch-
and-bound tree, column generation can be terminated earlier by stopping when no
column combined with the variables in {AS ∪ ISκ} is generated from the pricing
problem. Note that ISκ is determined at the column generation as:
ISκ ⊆ IS and |ISκ| ≤ κ− |AS|.
This can also prevent the tailing-off effect which makes column generation algo-
rithms difficult to proceed, as it drags the process through a large number of iterations
before proven optimality is achieved in the relaxation problem.
In terms of the practical solution time for IMRT treatment planning, an additional
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advantage results from every node consisting of a relatively small number of beam
variables in the branch-and-bound framework: in the mid of the solution process, we
can get a feasible solution easily (for actual clinical usage) by a few branching steps
of beam variables that are in the active set. Thus this active set approach can also
be viewed as a ”clinically adaptive” approach.
I Algorithm: Restricted Branch-and-Price for IMRT
Step 1. Initialize the best IP feasible solution, z?.
Step 2. Determine initial active set AS and inactive set IS and generate initial
RMP with AS.
Step 3. Solve the relaxation problem of current RMP .
Step 4. Update the best IP solution, z?, by this current solution if solution is
integral feasible, and whose optimal value is better than the current best
IP solution.
Step 5. Compute the lower bound, z. If z > z?, then go to Step 8.






, computed from the dual solution to the relaxation of RMP .
If columns are generated, add them to RMP and go to Step 3.
Step 7. If |AS| > Bmax, then do branching (on the active set), update the node
list, and (update RMP) and go to Step 3.
Step 8. Prune the node. If there exist a node unconquered at the node list, then




3.4.2 Initialization of AS and IS
Since the objective function of the pricing problem composes of the dual solution to
the relaxation problemRMP , we need to determine an initialRMP at the beginning
of the branch-and-price scheme. Obviously, the initial RMP must be feasible to its
relaxation problem so as to allow one to formulate the proper pricing problem. And
the ”better” the initial RMP is chosen, the better the performance of the overall
process will be.
In the applications to IMRT, our procedure starts with determining an initial
Active Set, AS, of beam orientations. Typically, it may be selected as a set of beams
with equi-spaced angles (i.e., 0, 40, 80, 120, 160, 200, 240, 280, and 320◦) within the
predetermined κ. A better collection of beams can be obtained by considering the
geometric information of PTV’s and critical structures based on clinical experience.
For example in the conventional conformal radiotherapy, the beam orientations are
selected according to the beam’s-eye view of PTV, which offers a good selection of
beams targeting the PTV while avoiding direct path to some critical structures.
3.4.3 Heuristic Algorithm for Column Generation
As mentioned in the previous section, we need to generate new columns with limited
number of original binary variables partly because of the difficulty of RMP , and
partly to maintain feasible and clinically acceptable plans during the solution process.
Therefore, we include the following constraint in the pricing problem:
∑
i∈IS
xi ≤ κ− |AS|. (70)
Note that since our RMP covers only variables in AS, we need to estimate the
dual variables, π0, corresponding to the constraints related to IS. From equations





where Dj is the j
th column vector of dose matrix, D. Thus, at ij constraint related
to IS, the value of a dual variable, πj0i , can be set to D
T
j πb.
Clearly, it is not easy to solve the pricing problem with binary variables. To
generate new column with the limited number of original binary variables, we derived
a heuristic method to find promising columns at a node based on the geometric
interpretation of spacing constraints.
Suppose that ASr and ISr be the active set and inactive set at current node r,






}. As soon as solving RMP at the node r, we can calculate di
for each i. Given di, for i ∈ {ASr \ASr(1)∪ ISr}, the heuristic algorithm for column
generation is following:
I Algorithm: Heuristic column generation
Step 1. Initialize new column index set, Ir ← ASr(1).
Step 2. Make the index set, I, whose elements are listed in the smallest order of di
Step 3. If |Ir ∩ ISr| = κ− |ASr|, update I ← I\ISr.
Step 4. If I = 0, then return ’no column found ’ message. Otherwise, choose the
first index, I(1), in I. And update I
r ← Ir ∪ {I(1)} and I ← I \ {I(1)}
Step 5. Delete unacceptable indices in I based on the constraints of geometric
spacing, (52) and (53). That is, as selecting a variable, xI(1) , the corre-
sponding variables to adjacent beams within ±∆o are fixed to 0 by the
minimum spacing constraints, (52). (See Figure 22. a) And the corre-
sponding variables to opposed beams (180o ± δ̆) are also fixed to 0 by the
opposite spacing constraints, (53). (See Figure 22. b)
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Step 6. If |Ir| < Bmax, go to step 3.
Step 7. If
∑
Ir di + π1 > 0, then update AS
r ← ASr ∪ Ir and ISr ← ISr\Ir, and





For general mixed integerMPs, one of the typical solution strategies is to branch on
the original integer variables so to be feasible to their integrality [7, 44]. Suppose the
solution to the relaxation of current RMP χ̄ has a fractional component, i, clearly,
χ̄ is infeasible to the original problem P . Thus, we have to do branching with the












Note that the component i is the element of the active set. In our experiments
on IMRT, when there exist several fractional components on χ̄ we choose the closest
component to 0. As the component i is fixed after branching, we need to update
ASr+1 and ISr+1 of its children. Clearly, the active set may not change at the child
node derived from the latter branch, dχ̄ie. Since this makes the redundant node to its
parents node, we will do branch recursively in this case. Suppose that ASr \ ASr(1)
is not empty. Given χ̄i, i ∈ ASr \ASr(1), the child nodes are generated as following:
I Algorithm: branching
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Step 1. Select i by argmin{χ̄i, i ∈ ASr \ ASr(1)}.
Step 2. For the former branch, bχ̄ic, we update that ASr+1 ← ASr\{i}.
Step 3. For the latter, dχ̄ie, we update the child as following:
◦ Check if beam i is conflicted with any beam in ASr(1), by similar way
to Step 5 in Algorithm: Heuristic column generation. If the beam i is
infeasible, this child node is pruned. Otherwise, update ASr+1(1) ←
ASr(1) ∪ {i}.
◦ If ASr+1(1) ≥ Bmax, then set ASr+1 \ ASr+1(1) ← 0 and ISr+1 ← 0
and goto Step 4.
◦ Update ASr+1 and ISr+1 by eliminating all beams in {ASr \ASr(1)∪
ISr} which are conflicted with beam i. If ASr+1 is identical to ASr,
set r ← r + 1 and goto Step 1.
Step 4. Stop.
J
3.4.5 Lower Bound and Early Termination
In a branch-and-bound tree in which branch-and-price algorithms perform, it is ad-
vantageous to find strong bounds at each node. The stronger the lower bound, LB,
the earlier the termination of the tree process: if LB is greater than the incumbent
integral solution value, then one can prune the current node, else if LB is greater than
the upper bound ofMP , then we can stop column generation. Moreover, this is very
important in terms of controlling the tailing-off effect [105]. However, there is a trade-
off in terms of the computational efforts. In generally it takes much computational
time to obtain a strong bound.
Proposition: Given a dual solution, π, toRMP , the lower bound of the relaxation
problem ofMP , zrLP , at node r is
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T Qy + cy + πTb (b−Dw + y)
+πTh (h−Gy + Hz) + πT0 (Ew − Fx)

= πb
T b + πh







T Qy + (c + πTb − πTh G)y
−(πTb D − πT0 E)w + πTh Hz − πT0 Fx
 .
Since π’s is an optimal solution to RMP , from the dual problem of RMP , we
have that for w ≥ 0, y ≥ 0, z ≥ 0,
−πbT y + πhT Gy − 2γρT Qy ≤ cy (71)
πb
T Dw − π0T Ew ≤ 0 (72)
−πhT Hz ≤ 0. (73)
Therefore, the lagrangian relaxation is bounded by
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{γyT Qy − 2γρT Qy − πT0 Fx}.
Since Q is positive definite and γ is positive, we also have that
0 ≤ γ(y − ρ)T Q(y − ρ)
= γyT Qy − 2γρT Qy + γρT Qρ
m
−γρT Qρ ≤ γyT Qy − 2γρT Qy. (74)
This means that
zrLP ≥ πbT b + πhT h +−γρT Qρ + minx∈Ξ∗(r){−πT0 Fx}
Finally, from the definition of coefficient matrix F , we can get the lower bound of
the relaxation problem. 2
Based on the above Proposition, we have derived the lower bound of the relaxed
MP at each node from the solution to the RMP relaxation by column generation
with the limited number of original binary variables. That is, if inactive set, ISr, is






enumerating the feasible set of beam angles in active set, ASr; otherwise, we obtain
the minimum value heuristically by taking Bmax number of beam variables in smallest
order of reduced cost, di.
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3.4.6 Solving RMP
The main purpose of solving the relaxation problem of RMP is to provide a good
dual solution which composes the objective function of the pricing problem.
In the case when there exists a optimal face defined by alternative dual solutions,
it is believed that the interior point methods return a better solution than the simplex
algorithm. Because an interior point algorithm searches a point in the relative interior
of the face, whereas the simplex algorithm enumerates and moves from one extreme
point to another. Further, computational tests have proved that RMP is far more
tractable using our in-house interior-point algorithm. Therefore, we applied our in-
house interior point algorithm, developed based on the concept from the predictor-
corrector algorithm [61, 62, 69, 82] to solve RMP . Lustig et al’s work is considered
one of the most popular interior-point algorithm to-date to solve large-scale linear
programming problems.
Despite the objective function of the relaxed RMP is quadratic, since Q is a diag-
onal matrix, the predictor-corrector algorithm can be readily applied to the relaxation
problem. Our QP algorithm described in Chapter 2 showed its efficiency based on
real clinical and patient cases. To improve the solution time within acceptable tol-
erance of the solution quality, we also incorporate the matrix reduction scheme that
we have described in Chapter 2 in solving RMP . In some senses, the devastation
resulting from reduced coefficient may be negligible. Further, the plan quality can
also be improved and achieved by the post-processing procedure described in Chapter
2.
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3.5 Computational and Clinical Results
3.5.1 Patient Data and Instance Generation
We use the Computational Environment for Radiotherapy Research (CERR) software
[31] to read in real patient images and generate the patient information and dose data
for treatment planning. CERRr, implemented Deasy’s group at Washington Univer-
sity in St. Louis, works on Matlabr environment and provides various functional
components including the routines of importing and visualizing the AAPM/RTOG
treatment planning format, the contouring tools to edit and/or create anatomical
structures, the routines of generating the influence matrix with a beam setup, and
the plan analysis tools to generate and visualize DVH graphes, iso-dose curves, and
dose color-washes from the solution to treatment planning. In particular, the influ-
ence matrix of each patient was calculated with the Quadrant Infinite Beam (QIB)
algorithm [46] which is a fast method of 3-D dose calculation based on Ahnesjos
approximation of kernel dose deposition patterns. Note that the influence matrix
consisting of primary dose as well as scatter and results in about 10% of density in
the coefficient matrix.
In our computational experiments, five patient cases including three Head-and-
Neck cases and two prostate cases were used. The beam orientations are discretized
using 10◦ over the gantry angle space and these beams were considered as the set
of potential candidate beams. The patient information and dose data involves are
very large scale and cannot be handled manually or interactively (as it takes too
much computational time). Moreover, we need additional information to determine
the instance parameters for IMRT treatment planning problems. Thus, we developed
several computer modules to support the modelling process, including
 Extracting the geometry information of beams and selecting a set of good can-
didate beams
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 Generating the dose matrix of each beam and extracting the spatial and organ
relational information
 Assembling all data and formulating the MIQP instances
 Solving the instances with various solution techniques
 Analyzing the quality of solution plan using various clinical metrics.
3.5.1.1 Prostate cancer
Prostate cancer is very common disease in older men in the United States, in par-
ticular, most prevalent in men over age 65. Recent statistics shows the incidence of
diagnosed prostate cancer has increased dramatically among American men.
Table 11 describes two prostate cases. And Table 12 summarizes the constraint
parameters for the beamlet intensity map optimization. As shown in both tables,
the prostate cases contain primary and secondary PTVs whose prescription doses are
specified at 75.6 Gy and 45 Gy, respectively. For their coverage constraints, at least 95
% of each PTV should receive its prescription dose. In addition to critical structures,
a 5-15mm critical-normal-tissue-ring whose voxels are selected from normal tissues
will be considered as one of the critical structures. For the rectum and the bladder,
the DV constraints specify that 70 % of the rectum and the bladder should receive
less than 70 and 80 Gy, respectively.
Table 11: Volume of each structure for the Prostate cases
Structures case1 case2
volume (cm3)
PTV 1 118.54 102.18
PTV 2 182.35 38.90
Bladder 98.32 148.18
Rectum 67.01 104.47
Left Femur head 0 162.04
Right Femur head 0 170.01
Unspecified Tissue 8072.11 10597.36
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Table 12: Constraint parameters for the beamlet intensity map at Prostate case
Structures Prdose Low Bd Upper Bd DVH
(Gy) (Gy) (Gy)
PTV 1 75.6 70.46 87.05 95% ≥ 75.6 Gy
PTV 2 45 44.25 87.05 95% ≥ 45 Gy
Bladder 0 0 87.05 70 % ≤ 80 Gy
Rectum 0 0 87.05 70 % ≤ 70 Gy
Left Femur head 0 0 87.05
Right Femur head 0 0 87.05
Unspecified Tissue 0 0 87.05
3.5.1.2 Head-and-Neck cancer
Head-and-neck cancer refers to a range of malignant tumors located in or around
the throat, larynx, nose, sinuses, and mouth. Hence, it affects seriously the vital
functions such as eating and breathing. According to 2007 report from American
Cancer Society, head-and-neck cancer accounts for about 3% to 5% of all cancers
in the United States. And it is estimated that about 45,660 people will develop
head-and-neck cancer, and about 11,210 will die from it. Table 13 describes three
head-and-neck cases, and Table 14 shows the clinical dose constraint parameters.
Table 13: Volume of each structure of the Head-and-Neck cases
Structures case1 case2 case3
volume (cm3)
PTV 1 266.39 253.34 105.3107
PTV 2 0 116.62 38.7295
PTV 3 430.64 285.47 522.3822
Spinal cord 20.66 24.35 9.9201
Brain stem 29.33 13.98 21.3629
Right Parotid 36.18 40.39 56.5862
Left Parotid 24.08 0 61.8214
Right Submandibular 20.59 0 0
Left Submandibular 0 0 9.4446
Unspecified Tissue 2666.93 3543.48 10954.21
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Table 14: Constraint parameters for the beamlet intensity map at Head-and-Neck
case
Structures Prdose Low Bd Upper Bd DVH
(Gy) (Gy) (Gy)
PTV 1 72 68.75 83.8 95% ≥ 72 Gy
PTV 2 54 52.65 83.8 95% ≥ 54 Gy
PTV 3 49.5 48.35 83.8 95% ≥ 49.5 Gy
Spinal cord 0 0 45
Brain stem 0 0 54
Right Parotid 0 0 76.32 50% ≤ 30
Left Parotid 0 0 76.32 50% ≤ 30
Right Submandibular 0 0 76.32 50% ≤ 30
Left Submandibular 0 0 76.32 50% ≤ 30
Unspecified Tissue 0 0 83.8
3.5.1.3 Determination of Beam Selection Parameters
In additions to dose/dose volume constraints, we will determine three types of pa-
rameters for the constraints associated with the beam angle selection as described at
section 3.2.4. Table 15 shows the parameter values of the maximum number of beam
angles allowed in any feasible plans and the beam-angle spacing constraints. Note
that ’∆ = 30◦’ means that the minimum angle between two adjacent beams is 30◦
and ’δ̆ = 0’ implies that two beams opposed directly cannot be selected at the same
time. As a result, we selected two sets of candidate beams, whose sizes are 15 and
20, based on the relationship of geometry between each beam and the anatomical
structures. Figure 23 illustrates the selected beams whose central rays escaping the
critical structures.
Table 15: Predetermined model parameters related to the selection of beam orien-





κ 8, 9, 10
# candidate beams 15, 20
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(a) Prostate case (b) Head-and-Neck case
Figure 23: Selection of candidate beams. Each indicates the central ray of beam.
Only solid line escaping the critical can be selected as a candidate beam.
Moreover, it is very important to establish the proper value of κ, the maximum
size of a active set, in restricting branch-and-price process and in maintaining each
feasible solution to be clinically acceptable. Further, this is critical also as the solution
time of the relaxation problem of RMP depends on the size of the active set. For
computational comparison, we determined three different values of κ and analyzed
how the size of κ affects the overall solution times.
3.5.2 Computational Results
The computational experiments have been carried out with the our ”in-house” op-
timization code based on the interior point algorithm and the branch-and-price al-
gorithm prescribed at the previous section. The following numerical results were
obtained when running our solvers on a 2.33 GHz Intel Xeon machine with 12 GB of
RAM.
As mentioned in previous sections, our dose matrix is large scale and relatively
dense. The size and density depend on which structures are included into the model,
and how the dose distribution is computed from the beamlets to voxels. In this
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research, we first observed that critical ring structures and scatter doses can be neg-
ligible in the selection of beam orientations. Based on these observations, the dose
matrices for the optimization problem of the beam angle selections can be reduced
into only primary doses computed from PTVs and the critical structures. This re-
duction improves drastically the computational time in solving relaxation of RMP
via the column generation method.
3.5.2.1 Optimization of Beam Orientations
Starting with the initial setups, we created MIQP instances and solved them by
restricted branch-and-price algorithm keeping the limited number of beams in the
active set. Consequently, we have six test-runs associated with the size of the active set
and the number of candidate beams at each patient case. Table 16 and 17 summarize
the computational statistics for each patient case. The third and fifth columns show
the total # QP and total # iterations used to solve the relaxation of QP in the entire
branch-and-price process, respectively. The last two columns show the CPU time
elapsed and the objective value of the optimal IP solution, respectively.
The computational results of both patient cases show similar trends to each other.
The solution time of active set = 8 is much faster than the other two cases, 9 and
10. Since increasing a few candidate beams may provide a large numbers of feasible
beam combinations, the solution times from 20 candidate beams are far much longer
than the ones from 15 beams.
We remark that the head-and-neck cases have much larger PTVs than the prostate
cases, thus result in much larger instances of RMP . As a result, every solution time
is longer than those from the prostate cases.
We have also investigated some scheme of ”warmstart” which may provide a good
initial solution for the child node within a branch-and-bound framework. From the
computational experiments of Lee and Mitchell [58], their ”advanced warmstart”
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showed the efficient performance on solving the instances of MIPLIB and the port-
folio problem. Unlike typical branch-and-bound algorithms, our branch-and-price
algorithm adds (or delete) hundreds of dense columns corresponding to each enter-
ing (or eliminating) beam at the child RMP. This causes a dramatic change of the
child node from its parent node. Consequently, the warm-start scheme applied to
our IMRT instances did not provide much solution time improvement at the series of
interior point iterations.
Table 16: Computational statistics at Prostate cases
Size of #candidate Relaxation of QP IP Solution
Active Set beams #QP #iterations CPU sec. Obj. Val.
case1
8 15 45 984 6911 1147.3
20 232 5059 34378 1144
9 15 197 4301 37793 1147.3
20 1229 26979 219278 1144
10 15 187 4079 44928 1147.3
20 1578 34629 278055 1144
case2
8 15 55 1545 967 1288.5
20 248 6812 4025 1263.3
9 15 174 4689 3438 1288.5
20 1311 34410 24379 1263.3
10 15 255 6935 5623 1288.5
20 1580 40944 29972 1263.3
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Table 17: Computational statistics at Head-and-Neck cases
Size of #candidate Relaxation of QP IP Solution
Active Set beams #QP #iterations CPU sec. Obj. Val.
case1
8 15 57 1511 10145 901.75
20 372 10263 60874 901.75
9 15 159 4211 38661 901.75
20 1499 40094 341585 901.75
10 15 185 4846 55963 901.75
20 1876 49882 460161 901.75
case2
8 15 64 1548 8651 166.12
20 393 9785 50254 161.11
9 15 159 3804 20629 166.12
20 1659 40837 219041 161.11
10 15 232 5505 41248 166.12
20 1798 43767 256555 161.11
case3
8 15 137 7001 15884 498.7
20 866 40128 91001 492.76
9 15 218 8699 26445 498.7
20 1965 67482 196461 492.76
10 15 276 10436 29282 498.7
20 2247 74121 221983 492.76
3.5.2.2 Optimization of Beam Intensity Map
In second phase, we optimized the beamlet intensity map with the full dose matrix
associated with the set of beam orientations obtained from the first phase. Table 18
shows the size of the instances generated from the optimal set of beams for each run
and the CPU time between our QP solver and Cplexr barrier algorithms.
3.5.3 Clinical Results
We presented here the treatment plans for one prostate case and one head-and-neck
case. Both have been processed using the optimal solutions obtained with 15 can-
didate beams. The solution plans are called the Column Generation Plans (CG-P).
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Table 18: Computational statistics for beamlet intensity map. Here, Error 1001
means ”CPLEX Error 1001: Out of memory”.
Patient #cand. Size of instances (preprocessed) CPU Sec
cases beams #nonzeros #rows #cols (#dense) QP SOL Cplexr
Prostate
case1 15 2525130 38640 11195 (1167) 352 85396
20 2540397 38640 11197 (1169) 379 96130
case2 15 1880233 37389 17499 (589 ) 189 41673
20 1873525 37445 17496 (587) 192 41733
Head-and-Neck
case1 15 3805826 65770 22632 (1649) 783 Error 1001
20 3805826 65770 22632 (1649) 783 Error 1001
case2 15 4004531 69820 16979 (1330) 975 Error 1001
20 4029571 69819 16986 (1337) 972 Error 1001
case3 15 3924922 83157 17952 (1227) 688 Error 1001
20 3940218 83667 18092 (1253) 576 Error 1001
Each plan is evaluated by graphical and statistical tools such as dose-washes, dose-
volume histogram, and statistical indices.
Figure 24 shows the dose-washes on the transverse view and sagittal view for our
column generation plan. A dose-wash picture describes the overall dose distribution
of the plan by scaled colors. Note that the color ranges from dark blue to dark red
indicate the dose values from 0 to the maximum dose. The picture of prostate case
(Figure 24 (a)) illustrates that most of rectum and bladder receive very low doses and
the higher doses of 75.6 Gy or greater cluster around the PTV7560 region, between on
bladder and rectum, and the PTV4500 placed above the rectum. Further, PTV7560
is covered by its prescription dose. In the head-and-neck case (Figure 24 (b)), the
treatment plan delivers relatively high doses to some normal tissues because of the
large PTVs that overlap with some of the critical structures. However, the plan spares
all the critical structures and achieves full coverage of the prescription dose to PTVs.
As described at section 3.2.3, a Dose-Volume Histogram depicts the relationship
between a dose level and the fractional volume of structure exposed greater than the
particular dose: for a series of dose levels represented on X-axis, the corresponding
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fractional values represented on Y-axis take the shape of curve. Note that a better
treatment plan makes vertical curves over the prescription doses for PTVs as well as
(a) Prostate case
(b) Head-and-Neck case
Figure 24: Dose-washes on a transverse and a sagittal view generated from the
optimal column generation plans. Scaled color bar indicates the various levels of dose
value.
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curves cluster low toward the Y-axis and X-axis for critical structures and normal
tissues. Moreover, by plotting several treatment plans at one graph, one can compare
the quality of the resulting plans. Figure 25 and 26 show the DVH curves comparing
the optimal column generation plan with the fixed beam plan (from clinic) for prostate
(a) PTV7560 and PTV4500
(b) critical structures and normal tissue
Figure 25: Dose-volume histograms at Prostate case. Note that the fixed beam plan
(clinical plan) was obtained with 7 equi-spaced beams.
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case and head-and-neck case, respectively. Here the Fixed Beam Plan, denoted as FB-
P, was obtained by solving the quadratic programming problems based on the dose-
based objective function with the 7 equi-spaced angles provided by the clinicians.
In addition to maximum, mean and minimum doses, several clinical metrics such
as coverage index, homogeneity index, conformity index, and Vα values are computed
to evaluate the treatment plans. The former three indices are used to the evaluation
(a) PTV7200 and PTV4950
(b) critical structures and normal tissue
Figure 26: Dose-volume histograms at Head-and-Neck case. Note that fixed beam
plan (clinical plan) was obtained with 7 equi-spaced beams.
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of PTV according to the Radiation Therapy Oncology Group (RTOG) guidelines.
Recall that homogeneity index was described in section 3.2.2. Coverage is computed
as the ratio of the target volume enclosed by the prescription isodose surface to the
total target volume. Thus the coverage of a plan is always less than or equal to 1.
Conformity is a measure of how well the prescription isodose surface conforms to the
target volume. That is, it is computed as the ratio of the total volume enclosed by
the prescription isodose surface to the target volume enclosed by this same surface.
Conformity is always greater than or equal to 1. And as described at section 3.2.3,
Vα is the fractional volume of a structure receiving greater than or equal to α dose.
For critical structures, the lower the Vα, the better the treatment plan. Table 19 - 22
contrasted the clinical metrics of the resulting plans.
Clearly, all metrics show that our column generation plans are much superior than
the fixed beam plans: column generation plan achieved more conformal plan to PTV
with less exposure to the critical structures. Specifically, 70% of rectum and bladder
received less than 40 Gy. And for the dose-volume constraints for the left parotid
and the right submandibular, each prescribed to receive less than 30 Gy, the column
generation plan spares more than 46% of left parotid and 31% of right submandibular
than the fixed beam plan.
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Table 19: DVH statistics of PTVs at Prostate case
PTV7560 PTV4500
CG-P/FB-P CG-P/FB-P
Max (Gy) 85.45/91.85 84.35/82.85
Mean (Gy) 78.45/81.87 48.35/48.90




Table 20: DVH statistics of critical structures and normal tissues at Prostate case
Rectum Bladder Tissue
CG-P/FB-P CG-P/FB-P CG-P/FB-P
Max (Gy) 75.45/81.95 82.45/84.55 90.75/89.05
Mean (Gy) 23.90/42.72 22.05/34.55 20.62/21.29
Min (Gy) 0.15/0.55 0.15/0.45 0.05/0.05
V20 0.487/0.766 0.414/0.624 0.475/0.523
V40 0.225/0.460 0.218/0.358 0.104/0.121
V60 0.068/0.189 0.078/0.143 0.013/0.014
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Table 21: DVH statistics of PTVs at Head-and-Neck case
PTV 7200 PTV 4950
CG-P/FB-P CG-P/FB-P
Max (Gy) 83.95/81.05 84.05/82.65
Mean (Gy) 75.85/75.05 59.90/63.25














R. parotid L. parotid R. submand. Tissue
CG-P/FB-P CG-P/FB-P CG-P/FB-P CG-P/FB-P
Max(Gy) 51.05/67.85 68.95/77.85 54.95/71.85 87.05/78.85
Mean(Gy) 7.61/17.91 20.91/37.97 20.59/42.1 29.79/30.86
Min(Gy) 0.05/5.45 0.15/2.25 2.65/17.15 0.05/0.05
V20 0.064/0.243 0.408/0.705 0.439/0.905 0.638/0.667
V40 0.008/0.035 0.202/0.500 0.124/0.591 0.351/0.362
V60 0/0.006 0.018/0.198 0/0.106 0.074/0.074
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3.6 Conclusion
A mixed-integer quadratic programming approach was presented for the optimization
problems of IMRT treatment planning. The proposed MIQP model allows one to
optimize simultaneously the beam orientations over the entire space of the gantry
angles and the beamlet intensity map. For computational efficiency, a restricted
branch-and-price method is derived to solve these large-scale MIQP instances arising
from clinical cases of prostate and head-and-neck cancer. Clinical experiments showed
that the solutions from our MIQP are far superior than those plans obtained in by
the current best-practice in the clinical environment.
Beyond drastically improving the computational time, the restricted branch-and-
price method provides an additional bonus: every node consists of only a relatively
small number of beam variables in the branch-and-bound framework. This implies
that in the middle of the solution process, a feasible solution obtained can be clinically
usable, and it can be readily obtained by a few branching steps of the beam variables
that are in the active set.
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